Diseases of liver

K11_LIVER

liver disease: A disease involving the liver.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K70-K77, K77.0B96.8 Cause of death:* ICD-10 — K70-K77, K77.0*B96.8 2 out of 7 registries used, show all original rules.	17941
4. Check minimum number of events None	17941
5. Include endpoints K11_ALCOLIV K11_TOXLIV K11_HEPFAIL K11_CHRONHEP K11_FIBROCHIRLIV K11_OTHINFLIV K11_DISLIVOTH K11_LIVDISINOTH	19250
6. Filter based on genotype QC (FinnGen only)	17277

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	K11_LIVER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_ALCOLIV\|K11_TOXLIV\|K11_HEPFAIL\|K11_CHRONHEP\|K11_FIBROCHIRLIV\|K11_OTHINFLIV\|K11_DISLIVOTH\|K11_LIVDISINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K7
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K7
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases of liver based on the number of shared cases.

Similar with more cases:

Gastrointestinal diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	150473	59607	88221
Only index persons	105531	46647	58884
Unadjusted period prevalence (%)
Whole population	2.17	1.71	2.46
Only index persons	2.01	1.71	2.25
Median age at first event (years)
Whole population	55.75	57.08	54.83
Only index persons	55.80	56.49	55.26

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	17277	8554	8723
Unadjusted period prevalence (%)	3.52	3.04	4.00
Median age at first event (years)	57.09	55.93	58.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17860: Matched controls
178596

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

323.0

3654

19233

A02BC02

ATC

pantoprazole; systemic

1.9

315.7

12791

101617

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

307.7

376

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.5

307.7

789

1096

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.0

307.7

2620

5980

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

9.9

307.7

731

766

57309

ICD-8 Finland

Other diseases of liver, Unspecified

+∞

307.7

335

T90

ICPC

Diabetes non-insulin dependent

2.2

307.7

5406

29915

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

10.7

307.7

574

550

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

24.3

307.7

2154

1002

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.1

307.7

978

2000

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.9

307.7

836

1270

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.7

307.7

4462

8468

C03DA01

ATC

spironolactone; oral

4.2

307.7

4151

11964

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.0

307.7

980

1721

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

307.7

6114

32915

A07AA11

ATC

rifaximin; oral

74.1

307.7

349

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.1

307.7

774

1316

K83.0

ICD-10 Finland

Cholangitis

8.8

307.7

683

804

R94.5

ICD-10 Finland

Abnormal results of liver function studies

7.8

307.7

616

814

K70.1

ICD-10 Finland

Alcoholic hepatitis

561.1

307.7

956

A06AD11

ATC

lactulose; oral

2.7

307.7

3493

14608

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

11.4

307.7

1009

933

A10AE04

ATC

insulin glargine; parenteral

2.7

307.7

2388

9600

K75.0

ICD-10 Finland

Abscess of liver

3882.9

307.7

390

F10.24

ICD-10 Finland

Alcohol depence active use

7.6

307.7

665

908

K76.80

ICD-10 Finland

Hepatic cyst

206.0

307.7

1029

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.9

307.7

559

830

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

170.2

307.7

448

C03CA01

ATC

furosemide; systemic

2.4

307.7

6676

35003

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

536.6

307.7

472

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

6.1

307.7

607

1027

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.3

307.7

431

530

N02AX02

ATC

tramadol; systemic, rectal

1.9

307.7

8648

58460

A05AA02

ATC

ursodeoxycholic acid; oral

27.3

307.7

1424

564

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

126.9

307.7

238

Z94.4

ICD-10 Finland

Liver transplant status

62.6

307.7

386

L04AX01

ATC

azathioprine; systemic

4.0

307.7

1265

3330

K70.4

ICD-10 Finland

Alcoholic hepatic failure

1223.5

307.7

592

K70.0

ICD-10 Finland

Alcoholic fatty liver

182.2

307.7

1063

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

131.8

307.7

1171

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

308.3

307.7

480

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

17.8

307.7

295

168

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

1502.1

307.7

2461

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

38.9

307.7

234

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

10.5

307.7

475

463

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.7

307.7

1187

3414

P15

ICPC

Chronic alcohol abuse

5.0

307.7

1092

2317

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

1717.9

307.7

1709

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.8

307.7

1055

1644

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.4

307.7

2495

11163

R18

ICD-10 Finland

Ascites

16.0

307.7

1396

940

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

8.0

307.7

464

591

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

1645.7

307.7

2295

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

9469

65596

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

5779.0

307.7

570

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

21.8

307.7

558

264

K72.9

ICD-10 Finland

Hepatic failure, unspecified

366.5

307.7

738

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

307.7

7032

45854

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

76.8

307.7

4656

816

K92.0

ICD-10 Finland

Haematemesis

6.0

307.7

890

1555

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

307.7

7907

35146

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

40.7

307.7

418

105

K74.3

ICD-10 Finland

Primary biliary cirrhosis

1919.4

307.7

869

D97

ICPC

Liver disease NOS

26.4

307.7

446

173

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.5

307.7

2476

10989

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

307.7

3275

14455

N07BB01

ATC

disulfiram; oral

3.7

307.7

1239

3555

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

45.3

307.7

1090

256

A07EA06

ATC

budesonide; oral, local oral

3.9

307.7

1054

2859

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

2088.9

307.7

635

A10BA02

ATC

metformin; oral

2.1

307.7

6037

34901

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

134.8

307.7

447

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.2

307.7

4645

13828

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

307.7

2487

11027

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.2

307.7

5483

30084

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

10.1

307.7

1213

1278

K76.89

ICD-10 Finland

Other specified diseases of liver

209.8

307.7

430

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

307.7

5553

29016

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

20.3

307.7

320

160

K76.9

ICD-10 Finland

Liver disease, unspecified

261.5

307.7

2262

JJC00

NOMESCO Finland

Allogenic transplantation of liver

182.7

307.7

323

A10AB05

ATC

insulin aspart; parenteral

2.7

306.7

1821

7205

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.8

302.6

477

714

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

302.3

3683

19880

K74.0

ICD-10 Finland

Hepatic fibrosis

2857.0

301.6

291

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

298.0

3659

19796

UJF32

NOMESCO Finland

Coloscopy

1.9

297.6

5224

31963

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

297.4

2199

9663

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.4

293.7

490

778

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

290.9

4494

26328

L04AA06

ATC

mycophenolic acid; systemic

5.0

289.3

640

1322

A10BH01

ATC

sitagliptin; oral

2.4

284.9

2138

9449

E66.00

ICD-10 Finland

Metabolic syndrome

2.9

281.1

1419

5147

K76.7

ICD-10 Finland

Hepatorenal syndrome

+∞

277.8

266

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.3

276.4

565

1089

K71.2

ICD-10 Finland

Toxic liver disease with acute hepatitis

1370.1

275.4

268

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.8

274.8

437

660

C07AA05

ATC

propranolol; systemic

2.0

268.6

3795

21488

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.1

267.5

363

459

K92.1

ICD-10 Finland

Melaena

2.9

249.0

1280

4680

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

246.4

855

2472

C07AG02

ATC

carvedilol; oral

2.8

244.4

1322

4965

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

244.3

988

3148

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.0

243.8

3219

17736

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.7

241.9

573

1252

127

Kela drug reimbursment

Transplant complication

5.1

240.2

513

1027

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

238.8

1968

9027

P16

ICPC

Acute alcohol abuse

5.0

238.3

522

1068

K72.1

ICD-10 Finland

Chronic hepatic failure

1164.0

235.8

230

N05CF01

ATC

zopiclone; oral

1.7

235.5

5876

39384

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.6

234.5

1439

5760

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

232.1

2250

11029

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.1

231.7

1045

3549

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

227.3

2423

12319

57300

ICD-8 Finland

Other diseases of liver, Hepatitis NUD

+∞

226.5

217

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

223.8

6004

40918

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

221.7

1413

5757

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.4

221.0

321

439

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.3

219.0

579

1379

UJK02

NOMESCO Finland

ERCP

3.8

218.9

687

1854

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

38.6

218.8

134

H02AB06

ATC

prednisolone; systemic

1.6

218.1

8655

65113

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

216.5

2295

11628

N06AX11

ATC

mirtazapine; oral

1.7

214.6

6202

42994

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

8.4

213.3

280

340

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

212.8

2231

11252

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.6

208.0

1323

5380

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

207.7

1678

7610

N05AH04

ATC

quetiapine; oral

1.9

207.5

3257

18908

JJA20

NOMESCO Finland

Open biopsy of liver

16.9

203.5

169

101

AA1AD

NOMESCO Finland

CT of head and brain

1.7

202.5

5326

35895

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.2

201.0

847

2761

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

200.6

2906

16418

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

198.5

1102

4184

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.4

197.8

748

2282

L04AD02

ATC

tacrolimus; systemic

5.8

197.8

364

636

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.3

197.7

336

543

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.3

193.0

390

743

E66.8

ICD-10 Finland

Other obesity

2.6

192.7

1185

4735

WX892

NOMESCO Finland

Monitored bed care

2.3

191.9

1579

7207

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

191.1

2091

10692

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

8.3

189.5

251

308

J01MA02

ATC

ciprofloxacin; systemic

1.6

188.5

6988

51105

R50.9

ICD-10 Finland

Fever, unspecified

1.9

188.3

2885

16567

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.1

187.4

229

254

N05BA04

ATC

oxazepam; oral

1.7

183.0

4627

30704

A10AC01

ATC

insulin (human); parenteral

2.3

182.2

1452

6532

L04AD01

ATC

ciclosporin; systemic

4.2

181.9

501

1230

N06AB04

ATC

citalopram; systemic

1.8

180.0

3708

23248

TK800

NOMESCO Finland

Hemodialysis

3.8

179.2

561

1510

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.5

179.1

296

465

A10BJ06

ATC

semaglutide; parenteral

2.5

177.2

1201

5022

N05CD07

ATC

temazepam; oral

2.0

177.1

2139

11318

E87.6

ICD-10 Finland

Hypokalaemia

3.0

176.8

799

2710

N05BA02

ATC

chlordiazepoxide; systemic

3.6

176.8

592

1668

M04AA01

ATC

allopurinol; systemic

1.9

176.4

2500

13970

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.2

176.1

483

1182

Z72.1

ICD-10 Finland

Alcohol use

5.0

175.1

379

767

SPAT1262

SPAT

Handing over of treatment supplies

1.8

175.1

3212

19456

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

6.6

175.0

285

441

J01MA12

ATC

levofloxacin; systemic

1.8

174.9

3430

21184

ZXD05

NOMESCO Finland

Urgent procedure

1.6

174.2

5154

35521

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.9

173.1

527

1391

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

4.3

172.7

450

1059

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

172.6

808

2796

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

1748.1

171.0

166

L01BB02

ATC

mercaptopurine; oral

5.5

170.8

333

614

Z2446

NOMESCO Finland

Social worker

2.4

169.8

1243

5381

Q44.6

ICD-10 Finland

Cystic disease of liver

23.2

169.1

122

K29.2

ICD-10 Finland

Alcoholic gastritis

15.1

168.1

148

JN4AD

NOMESCO Finland

Body CT examination

1.9

164.3

2291

12713

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

164.1

1084

4475

N05BA01

ATC

diazepam; systemic, rectal

1.9

163.9

2350

13159

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

163.9

3212

19792

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

163.1

2202

12086

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

162.8

5530

39269

K71.9

ICD-10 Finland

Toxic liver disease, unspecified

326.1

161.2

163

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

5.0

160.6

347

701

Z3231

NOMESCO Finland

Registered nurse

1.6

159.4

4743

32597

R11

ICD-10 Finland

Nausea and vomiting

2.1

157.1

1597

7912

C07AB07

ATC

bisoprolol; oral

1.5

157.1

8419

65986

R4110

NOMESCO Finland

Physiotherapy

1.6

157.1

4925

34255

K75.2

ICD-10 Finland

Nonspecific reactive hepatitis

204.3

156.2

162

I81

ICD-10 Finland

Portal vein thrombosis

10.0

156.0

178

180

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

7.3

155.9

228

314

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

52.0

153.7

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.7

152.4

286

509

N06AX16

ATC

venlafaxine; oral

1.8

152.0

2509

14663

JJ1AT

NOMESCO Finland

Puncture of lesion of liver with ultrasound guidance

41.6

151.3

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.2

148.6

308

600

A46

ICD-10 Finland

Erysipelas

1.8

148.0

2766

16761

C10AC01

ATC

colestyramine; oral

3.1

147.9

635

2089

A10AE05

ATC

insulin detemir; parenteral

2.4

147.7

1051

4486

ZX120

NOMESCO Finland

Intravenous

2.0

147.5

1740

9098

K83.1

ICD-10 Finland

Obstruction of bile duct

4.4

147.5

377

874

A10BK03

ATC

empagliflozin; oral

1.9

147.2

2021

11130

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

147.2

2920

17997

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

26.5

145.6

100

Z2221

NOMESCO Finland

Medical doctor

1.6

144.3

4552

31586

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

16.9

143.3

119

J01FF01

ATC

clindamycin; systemic

1.6

141.3

4716

33127

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.5

141.1

911

3715

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

140.7

2394

14094

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

139.9

731

2681

Z3226

NOMESCO Finland

Physiotherapist

1.7

139.8

3103

19695

K51.5

ICD-10 Finland

Left sided colitis

3.1

139.4

600

1976

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

12.9

138.1

133

104

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.5

138.1

482

1395

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

138.0

4470

31153

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.1

137.7

388

968

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

+∞

137.7

132

A07EC02

ATC

mesalazine; oral, rectal

2.4

137.1

1045

4596

SPAT1265

SPAT

Breathalyser

5.4

136.3

270

505

ZXE00

NOMESCO Finland

One hour or less

1.5

135.6

6388

48266

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.2

135.4

547

1735

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

135.0

1245

5927

57308

ICD-8 Finland

Other diseases of liver, Alii definiti

+∞

134.5

129

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

134.3

2363

14036

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

134.2

4409

30795

G93.4

ICD-10 Finland

Encephalopathy, unspecified

13.9

133.7

123

198

Kela drug reimbursment

Sorafenib

13.9

133.7

123

WX002

NOMESCO Finland

Sedation and analgesia

1.7

132.7

3279

21372

A02BC01

ATC

omeprazole; systemic

1.6

132.6

4569

32244

R06.0

ICD-10 Finland

Dyspnoea

1.6

132.4

4666

33095

205

Kela drug reimbursment

Chronic hypertension

1.6

132.3

4437

31117

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

129.4

1186

5629

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

129.0

2306

13748

JJ5AT, ,

NOMESCO Finland

192.9

128.8

134

K76.6

ICD-10 Finland

Portal hypertension

1257.9

128.3

125

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

+∞

128.3

123

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

126.3

1967

11247

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

126.3

850

3532

A10BB12

ATC

glimepiride; oral

2.2

126.3

1194

5736

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

27.5

125.4

K29.6

ICD-10 Finland

Other gastritis

4.5

124.0

302

674

N03AX16

ATC

[U] pregabalin

1.6

123.4

3931

27179

N02AA05

ATC

oxycodone; systemic

1.6

123.2

3147

20640

5719X

ICD-9 Finland

Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol

+∞

123.0

118

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

9.3

122.9

148

161

K85

ICD-10 Finland

Acute pancreatitis

3.8

121.9

385

1042

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

121.7

629

2293

N06AB10

ATC

escitalopram; oral

1.6

118.8

3306

22119

A02BC05

ATC

esomeprazole; systemic

1.5

118.6

6878

53734

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.9

118.5

586

2086

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

117.7

1355

7000

UJD02

NOMESCO Finland

Gastroscopy

2.3

117.5

905

3992

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

117.5

10536

89153

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.7

117.2

382

1056

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.4

115.2

811

3438

E87.2

ICD-10 Finland

Acidosis

6.6

114.8

184

280

S97

ICPC

Chronic ulcer skin

2.1

114.4

1190

5923

A10BH05

ATC

linagliptin; oral

2.3

114.1

960

4396

P01AB01

ATC

metronidazole; oral, rectal

1.4

113.0

6512

50684

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

112.8

1365

7173

A10BJ02

ATC

liraglutide; parenteral

2.7

112.5

620

2336

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

7.2

111.6

166

233

H02AB07

ATC

prednisone; oral

1.7

111.4

2281

14087

R53

ICD-10 Finland

Malaise and fatigue

1.5

111.3

4152

29619

N17.8

ICD-10 Finland

Other acute renal failure

4.1

111.3

313

780

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

110.5

688

2754

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

110.2

1821

10576

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

110.1

708

2877

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

110.1

4302

30979

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

109.4

3912

27637

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.9

107.2

324

850

N05AB01

ATC

dixyrazine; systemic

4.1

106.9

299

742

R4190

NOMESCO Finland

Nutritional therapy

2.4

106.2

769

3300

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.2

104.9

279

667

I86.4

ICD-10 Finland

Gastric varices

27.4

104.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

104.5

2191

13603

UJK12

NOMESCO Finland

Peroral cholangioscopy

10.4

104.2

115

111

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.3

103.6

408

1274

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

21.5

103.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

103.2

5760

44363

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

102.4

1192

6174

N06AB03

ATC

fluoxetine; oral

1.7

101.9

1997

12165

A28

ICPC

Limited function/disability NOS

1.6

101.9

2869

19169

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

101.7

575

2194

WW500

NOMESCO Finland

Blood transfusion

2.4

101.7

754

3269

A02BC03

ATC

lansoprazole; oral

1.5

101.7

4668

34627

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

8.1

101.3

135

167

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

7.5

100.9

144

193

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

100.9

3104

21163

A10BG03

ATC

pioglitazone; oral

2.8

100.9

515

1864

E87.5

ICD-10 Finland

Hyperkalaemia

3.2

100.8

405

1280

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

99.1

739

3211

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

98.5

6819

54456

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

7.7

97.7

137

180

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.6

97.5

580

2269

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

97.2

1424

7958

L28

ICPC

Limited function/disability (L)

1.5

96.1

3096

21303

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.4

95.5

343

1011

UJF92

NOMESCO Finland

Capsular endoscopy

3.0

95.0

441

1515

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

95.0

1127

5871

K50.8

ICD-10 Finland

Other Crohn disease

3.6

94.6

323

921

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

94.4

3216

22387

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

94.2

2153

13645

N05AA02

ATC

levomepromazine; systemic

2.3

93.2

727

3220

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

92.9

2013

12581

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

5.1

92.5

195

386

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

92.4

894

4322

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

92.0

6001

47278

E83.1

ICD-10 Finland

Disorders of iron metabolism

5.7

91.8

170

299

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

9.1

91.5

111

122

K76.1

ICD-10 Finland

Chronic passive congestion of liver

893.3

90.9

5718X

ICD-9 Finland

Chronic liver disease and cirrhosis, Other chronic nonalcoholic liver disease

+∞

90.7

M10.9

ICD-10 Finland

Gout, unspecified

1.9

90.5

1261

6930

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.7

90.2

510

1945

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

89.6

WX402

NOMESCO Finland

General anaesthesia

1.5

89.5

3746

27172

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

17.4

89.4

R60.0

ICD-10 Finland

Localized oedema

1.6

89.1

2126

13608

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

88.9

592

2444

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.0

88.5

157

265

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

9.8

88.3

102

105

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

88.2

891

4377

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

87.9

793

3729

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.8

87.9

457

1670

5712A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic cirrhosis of liver

+∞

87.6

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

87.3

850

4117

V03AA01, ,

ATC

3.2

87.2

348

1095

N05CF02

ATC

zolpidem; oral

1.5

86.6

2792

19164

K71.0

ICD-10 Finland

Toxic liver disease with cholestasis

+∞

86.5

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

13.9

86.0

C08CA01

ATC

amlodipine; oral

1.4

85.9

6363

51048

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

10.0

85.7

A41.8

ICD-10 Finland

Other specified sepsis

3.0

84.7

385

1307

B01AB05

ATC

enoxaparin; parenteral

1.4

84.7

5097

39467

E0000UV, ,

ATC

1.4

84.6

6700

54295

JJ4AT

NOMESCO Finland

Catherisation of liver lesion with ultrasound guidance

49.1

84.3

TJA10

NOMESCO Finland

Laparocentesis

8.1

83.8

112

139

J01DB01

ATC

cefalexin; oral

1.4

83.7

14078

128602

I50.0

ICD-10 Finland

Congestive heart failure

1.9

83.5

1181

6515

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

13.0

83.5

160

Kela drug reimbursment

exenatide

2.9

83.3

402

1411

A10BK01

ATC

dapagliflozin; oral

1.8

83.3

1413

8241

JJA31

NOMESCO Finland

Laparoscopic marsupialisation of cyst of liver

409.6

82.0

N19

ICD-10 Finland

Unspecified kidney failure

2.3

81.4

651

2913

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

81.2

4643

35583

JN4CD

NOMESCO Finland

Very extensive body CT

2.3

81.0

645

2881

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

80.4

490

1939

WX882

NOMESCO Finland

High dependency care

2.5

80.3

528

2167

N03AX12

ATC

[U] gabapentin; oral

1.5

79.8

2578

17674

L01XE05

ATC

[U] sorafenib

14.9

79.2

J01DA01

ATC

[U] cefalexin

1.3

79.0

9985

86592

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

8.5

78.9

101

119

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

78.6

1519

9184

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

5.5

78.6

153

282

E86

ICD-10 Finland

Volume depletion

2.6

78.5

455

1757

SPAT1247

SPAT

Outpatient detoxication and monitoring

5.9

78.4

140

238

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

78.2

772

3758

WX872

NOMESCO Finland

Intensive care

2.0

77.7

910

4712

R03AC02

ATC

salbutamol; inhalant

1.3

77.4

8841

75419

R02

ICPC

Shortness of breath/dyspnoea

1.6

77.4

2214

14764

N05BA12

ATC

alprazolam; oral

1.7

77.3

1578

9683

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

76.5

777

3822

5711A

ICD-9 Finland

Chronic liver disease and cirrhosis, Acute alcoholic hepatitis

+∞

76.1

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

13.4

75.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

75.6

3090

22213

N06AX03

ATC

mianserin; oral

2.0

75.1

802

4018

H02AB04

ATC

methylprednisolone; systemic

1.5

75.1

2289

15476

57101

ICD-8 Finland

Cirrhosis of liver, Degeneratio hepatica adiposa alcoholica

+∞

75.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

74.9

2424

16604

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.8

74.6

378

1362

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

74.4

687

3258

T82

ICPC

Obesity

2.1

74.0

721

3492

D01

ICPC

Abdominal pain/cramps general

1.6

73.6

1903

12384

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

73.1

1033

5693

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

73.0

6000

48590

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

72.7

1743

11135

R10.0

ICD-10 Finland

Acute abdomen

2.3

72.2

580

2599

D13.4

ICD-10 Finland

Benign neoplasm: Liver

5.1

71.7

150

295

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

7.9

71.7

125

N06AX21

ATC

duloxetine; oral

1.6

71.5

1900

12440

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.2

71.1

290

925

D07AC01

ATC

betamethasone; topical

1.4

71.1

5860

47427

A02BA02

ATC

ranitidine; systemic

1.5

70.8

2934

21118

SPAT1240

SPAT

Therapeutic discussion

1.7

70.6

1469

9051

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

69.9

2998

21717

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

69.8

1554

9740

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

3.9

69.8

210

550

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

69.6

349

1251

P76

ICPC

Depressive disorder

1.9

69.4

996

5513

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

69.3

970

5326

S01.0

ICD-10 Finland

Open wound of scalp

1.7

69.1

1331

8029

ZY010

NOMESCO Finland

Hospital outpatient

2.0

69.1

787

4034

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

69.0

1248

7399

SPAT1227

SPAT

Substance abuse rehabilitation

4.7

68.6

160

345

WVA20

NOMESCO Finland

Medicine administration

2.3

68.6

527

2318

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.4

68.2

243

713

JN4BD

NOMESCO Finland

Extensive body CT

1.6

68.1

1628

10384

S06.0

ICD-10 Finland

Concussion

1.6

68.1

1685

10839

N06AB06

ATC

sertraline; oral

1.6

67.9

1711

11056

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

3.6

67.8

222

616

P03

ICPC

Feeling depressed

1.7

67.4

1417

8748

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

4.4

66.8

169

389

K65.0

ICD-10 Finland

Acute peritonitis

3.4

66.7

240

709

A01

ICPC

Pain general/multiple sites

1.6

66.6

1606

10265

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

11.2

66.5

A10BJ05

ATC

dulaglutide; parenteral

2.6

66.4

389

1510

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.1

65.8

275

890

K75.3

ICD-10 Finland

Granulomatous hepatitis, not elsewhere classified

+∞

65.7

G47.3

ICD-10 Finland

Sleep apnoea

1.4

65.6

3925

30115

A12BA01

ATC

potassium chloride; oral

2.1

65.6

625

3000

W19

ICD-10 Finland

Unspecified fall

1.6

65.4

1586

10148

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.2

65.3

579

2701

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

65.2

3421

25664

323

Kela drug reimbursment

Sorafenib

12.6

64.8

N06AA09

ATC

amitriptyline; systemic

1.6

64.7

1472

9269

B15.9

ICD-10 Finland

Hepatitis A without hepatic coma

24.3

64.7

57009

ICD-8 Finland

Acute and subacute necrosis of liver, Unspecified

+∞

64.6

A98

ICPC

Health maint/preventive medicine

0.7

64.4

15559

162545

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

64.3

477

2066

F05.9

ICD-10 Finland

Delirium, unspecified

2.6

64.3

384

1505

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

4.4

64.3

162

372

JJ5KT

NOMESCO Finland

Sclerotherapy of liver cyst

220.8

64.2

Z51.5

ICD-10 Finland

Palliative care

1.7

63.9

1383

8598

T89

ICPC

Diabetes insulin dependent

2.1

63.8

655

3234

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

63.7

2108

14470

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

23.1

63.5

A08

ICPC

Swelling

1.8

63.5

926

5150

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

63.4

4092

31758

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

19.7

63.3

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.4

63.3

465

2006

B17.1

ICD-10 Finland

Acute hepatitis C

12.2

63.2

K51.8

ICD-10 Finland

Other ulcerative colitis

3.0

63.0

276

918

K70

ICD-10 Finland

Alcoholic liver disease

87.9

62.9

C09AA02

ATC

enalapril; systemic

1.4

62.8

2932

21527

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

62.8

785

4153

57100

ICD-8 Finland

Cirrhosis of liver, Cirrhosis cum alcoholismo

+∞

62.5

SPAT1254

SPAT

Administration of medicine

1.5

62.5

2175

15084

309

Kela drug reimbursment

Nalmefene and naltrexone

5.2

62.5

129

251

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.0

62.3

729

3770

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

62.1

2831

20693

D02

ICPC

Abdominal pain epigastric

1.8

61.9

982

5600

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

61.8

3731

28626

H03AA01

ATC

levothyroxine sodium; systemic

1.4

61.6

3392

25627

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

61.5

1465

9327

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

61.3

11727

105839

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

5.2

61.3

127

248

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

60.8

498

2250

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

600.4

60.8

N03AX09

ATC

lamotrigine; oral

2.0

60.8

722

3754

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

60.7

639

3183

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

3.7

60.4

191

518

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

3.2

60.3

244

775

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

60.3

1941

13237

N06AA12

ATC

doxepin; systemic

1.9

60.3

797

4295

L17

ICPC

Foot/toe symptom/complaint

1.3

60.1

4851

38905

SPAT1255

SPAT

Intravenous administration of medicine

1.7

60.1

1059

6226

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

59.8

884

4934

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.9

59.7

277

952

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

59.5

1543

10025

R04.0

ICD-10 Finland

Epistaxis

1.7

59.1

1203

7358

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.4

59.0

209

611

D73.1

ICD-10 Finland

Hypersplenism

12.1

59.0

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

58.8

2159

15126

R06AE07

ATC

cetirizine; oral

1.3

58.3

6724

56623

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.8

58.1

130

271

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

7.0

57.8

124

K77.0*B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

570.1

57.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

57.6

390

1622

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

57.6

268

923

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

57.4

1015

5971

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

57.0

670

3471

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

56.9

715

3787

C09AA05

ATC

ramipril; oral

1.4

56.9

3848

30004

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

56.9

522

2469

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.6

56.8

322

1230

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

56.8

1952

13485

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

3.3

56.8

214

651

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

56.7

1516

9914

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

56.4

1232

7670

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

56.4

1127

6856

P19

ICPC

Drug abuse

3.9

56.4

167

433

H02AB09

ATC

hydrocortisone; systemic

2.4

56.3

399

1694

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

56.3

2961

22158

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

56.2

1531

10054

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

56.1

891

5082

A10BX07

ATC

[U] liraglutide

3.0

56.0

248

831

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

56.0

747

4037

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

55.8

2011

14025

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

4.4

55.7

139

317

JAH00

NOMESCO Finland

Laparotomy

2.2

55.4

459

2083

N05BE01

ATC

buspirone; oral

2.2

55.3

480

2220

C07AB02

ATC

metoprolol; systemic

1.4

55.3

2934

21981

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

55.2

631

3236

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.0

55.1

247

833

N30.0

ICD-10 Finland

Acute cystitis

1.4

55.1

2444

17736

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

55.0

1456

9495

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

4.8

54.9

122

253

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.5

54.8

186

529

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.1

54.6

235

774

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

54.6

1889

13063

S22.3

ICD-10 Finland

Fracture of rib

1.7

54.5

1168

7235

R41.0

ICD-10 Finland

Disorientation, unspecified

2.2

54.4

492

2313

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

54.2

786

4360

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.6

53.9

182

516

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

5.4

53.9

105

194

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

53.6

611

3130

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

4.6

53.6

127

278

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

53.4

253

880

K80.8

ICD-10 Finland

Other cholelithiasis

2.6

53.2

302

1155

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

3.9

53.2

159

415

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

53.1

390

1683

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

53.0

8260

71963

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

53.0

4476

36008

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.6

52.8

176

495

L01EX02

ATC

sorafenib; oral

14.7

52.7

K81.0

ICD-10 Finland

Acute cholecystitis

2.5

52.7

347

1425

S18

ICPC

Laceration/cut

1.3

52.7

7587

65440

N06AB05

ATC

paroxetine; oral

1.8

52.6

897

5221

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

52.6

2164

15477

K07

ICPC

Swollen ankles/oedema

1.9

52.5

742

4082

A04

ICPC

Weakness/tiredness general

1.4

52.5

2317

16787

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

52.3

1028

6224

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.5

52.2

330

1330

E000001, ,

ATC

1.4

52.1

2843

21375

N06AX12

ATC

bupropion; oral

1.7

52.1

1021

6177

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

52.1

574

2907

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

52.0

399

1754

M79.6

ICD-10 Finland

Pain in limb

1.3

51.7

6963

59521

RS220, ,

NOMESCO Finland

3.0

51.5

229

769

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

8.1

51.5

OAB50, ,

SPAT

1.6

51.5

1326

8590

F34.1

ICD-10 Finland

Dysthymia

2.0

51.4

550

2756

5714X

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]

+∞

51.1

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

51.0

718

3945

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

51.0

693

3766

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

19.1

51.0

WX730

NOMESCO Finland

Conventional respirator

2.7

50.7

279

1051

N05AX12

ATC

aripiprazole; systemic

2.0

50.3

562

2859

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

50.3

1016

6194

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

50.3

407

1830

L04AA01

ATC

[U] ciclosporin

2.8

50.2

249

888

D05AX52

ATC

calcipotriol, combinations; topical

1.7

50.2

870

5087

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

50.2

346

1452

K76

ICD-10 Finland

Other diseases of liver

14.5

50.1

K30

ICD-10 Finland

Functional dyspepsia

1.5

50.1

1719

11853

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

50.0

1295

8396

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

3.8

49.7

150

394

TK810

NOMESCO Finland

Hemofiltration

4.0

49.7

142

359

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

49.5

1896

13365

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

49.4

1309

8531

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

49.4

869

5103

N06AX26

ATC

vortioxetine; oral

1.6

49.3

1084

6753

J01FA06

ATC

roxithromycin; oral

1.3

49.3

5982

50384

L04AC05

ATC

ustekinumab; parenteral

4.5

49.2

121

273

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

49.1

580

3008

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

8.6

49.0

5716A

ICD-9 Finland

Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]

+∞

49.0

57301

ICD-8 Finland

Other diseases of liver, Degeneratio hepatica NUD

+∞

49.0

N05AH03

ATC

olanzapine; systemic

1.7

48.9

926

5547

SPAT1263

SPAT

Sampling

1.3

48.9

6220

52682

JCA20

NOMESCO Finland

Ligature of oesophageal varices

170.5

48.9

E66

ICD-10 Finland

Obesity

1.7

48.8

839

4893

D64.8

ICD-10 Finland

Other specified anaemias

2.5

48.8

317

1294

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

5.5

48.8

172

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

4.0

48.6

140

356

3AC01, ,

NOMESCO Finland

3.3

48.6

184

562

S76

ICPC

Skin infection other

1.7

48.5

853

5008

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.1

48.4

481

2345

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

48.4

433

2028

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

48.4

6938

59602

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

48.2

5620

47068

D11

ICPC

Diarrhoea

1.5

48.2

1721

11961

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

48.0

816

4744

R51.80

ICD-10 Finland

Headache

1.4

47.9

2236

16343

E51.2

ICD-10 Finland

Wernicke encephalopathy

10.9

47.7

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

47.5

215

730

V03AB30, ,

ATC

3.8

47.4

147

394

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

47.4

886

5290

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.5

47.3

308

1259

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.1

47.3

435

2060

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

47.2

2836

21621

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

47.2

486

2402

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

47.1

811

4733

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

46.9

1158

7421

JKA20

NOMESCO Finland

Cholecystectomy

2.2

46.9

417

1948

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

46.9

744

4239

162

Kela drug reimbursment

liraglutide

2.9

46.9

215

735

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

16.0

46.9

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.1

46.8

427

2016

D10

ICPC

Vomiting

1.8

46.5

782

4531

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

46.5

1451

9802

D07XC01

ATC

betamethasone; topical

1.5

46.4

1808

12775

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

46.3

385

1751

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

46.3

702

3947

EBA00

NOMESCO Finland

Extraction of tooth

1.3

46.1

5573

46813

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

46.1

947

5796

K85.8

ICD-10 Finland

Other acute pancreatitis

3.6

45.8

153

431

5713X

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic liver damage, unspecified

+∞

45.8

N05AF03

ATC

chlorprothixene; systemic

2.2

45.8

408

1908

RD210, ,

NOMESCO Finland

2.5

45.7

279

1107

B01AA03

ATC

warfarin; systemic

1.4

45.5

2681

20363

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

45.5

1785

12630

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

45.3

716

4076

P01

ICPC

Feeling anxious/nervous/tense

1.5

45.3

1540

10591

K71.1

ICD-10 Finland

Toxic liver disease with hepatic necrosis

449.0

45.3

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.7

45.3

241

893

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

7.2

45.2

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

45.1

272

1072

M01AB01

ATC

indometacin; systemic, rectal

1.6

45.1

1097

7003

OAB43, ,

SPAT

0.7

44.9

2696

34776

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.9

44.9

578

3086

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

6.6

44.9

110

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

8.2

44.8

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

4.3

44.7

116

273

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.2

44.7

178

561

T74.1

ICD-10 Finland

Physical abuse

2.5

44.4

278

1116

5739X

ICD-9 Finland

Other disorders of liver, Unspecified disorder of liver

9.5

44.1

ZXD35

NOMESCO Finland

Usual procedure

2.0

44.1

501

2564

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

44.1

3062

23845

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.3

44.0

351

1570

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

7.3

43.9

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.0

43.8

191

635

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

43.7

237

887

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

7.6

43.6

C01AA05

ATC

digoxin; systemic

1.6

43.6

1053

6712

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.8

43.5

202

M54.5

ICD-10 Finland

Low back pain

1.3

43.5

5630

47601

K08.3

ICD-10 Finland

Retained dental root

1.5

43.3

1236

8186

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.6

43.2

249

960

SPAT1281

SPAT

Other administrative function

1.6

42.9

1092

7044

S10

ICPC

Boil/carbuncle

1.7

42.9

903

5561

K73.89

ICD-10 Finland

Other long-term hepatitis, not classified differently

+∞

42.7

B82

ICPC

Anaemia other/unspecified

2.0

42.6

449

2238

6611

FHL

Needle biopsy in the operating room

12.8

42.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

42.5

3268

25812

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

42.4

378

1768

C10AB05

ATC

fenofibrate; oral

2.3

42.3

314

1362

N02BF02

ATC

pregabalin; oral

1.6

42.3

1037

6632

G72.8

ICD-10 Finland

Other specified myopathies

2.5

42.3

264

1059

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

5.3

42.2

162

D25

ICPC

Abdominal distension

2.3

41.9

315

1374

I85

ICD-10 Finland

Oesophageal varices

215.5

41.9

P29

ICPC

Psychological sympt/compl other

1.6

41.8

974

6151

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

3.7

41.7

134

368

PC2SC

NOMESCO Finland

Liver angiography with X-ray

12.9

41.7

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

41.6

1117

7294

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

41.6

461

2339

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

4.6

41.6

210

A07AA09

ATC

vancomycin; oral

2.6

41.5

245

956

Z72.2

ICD-10 Finland

Drug use

4.4

41.3

103

235

L04AB04

ATC

adalimumab; parenteral

2.2

41.3

357

1650

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

3.4

41.3

150

447

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3.5

41.0

138

391

K02.1

ICD-10 Finland

Caries of dentine

1.2

41.0

9240

82922

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

40.9

4367

36005

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

40.8

2652

20420

D07AA02

ATC

hydrocortisone; topical

1.4

40.8

1911

13949

K86.2

ICD-10 Finland

Cyst of pancreas

2.8

40.8

204

732

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.6

40.8

137

388

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

40.7

354

1640

R52.2

ICD-10 Finland

Other chronic pain

1.9

40.7

567

3105

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

40.7

1017

6532

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

7.6

40.7

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

5.3

40.7

153

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

4.6

40.6

206

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

+∞

40.6

K71.6

ICD-10 Finland

Toxic liver disease with hepatitis, not elsewhere classified

+∞

40.6

R03BB04

ATC

tiotropium bromide; inhalant

1.5

40.6

1476

10277

F32

ICD-10 Finland

Depressive episode

1.7

40.5

735

4350

A10AE06

ATC

insulin degludec; parenteral

1.9

40.4

544

2948

Z71.8

ICD-10 Finland

Other specified counselling

1.3

40.3

5115

43054

A99

ICPC

Disease/condition unspecnature/site

1.5

40.3

1548

10897

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

40.2

593

3305

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

6.2

40.1

110

A03

ICPC

Fever

1.4

40.1

2418

18400

A10AD05

ATC

insulin aspart; parenteral

2.4

40.0

265

1093

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

6.9

39.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

39.6

630

3591

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

39.6

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

5.0

39.6

168

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

39.4

776

4695

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

39.4

657

3798

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

39.3

4457

36987

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

3.6

39.1

129

361

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

39.1

334

1537

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.4

39.0

217

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

38.9

1003

6487

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

38.9

980

6306

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

4.9

38.8

171

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

8.6

38.7

A10BX04

ATC

[U] exenatide

2.9

38.7

184

643

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

38.6

1263

8605

SPAT1229

SPAT

Assessment of need for aid

1.6

38.6

1044

6828

N03AE01

ATC

clonazepam; systemic

1.6

38.6

830

5139

J02AC01

ATC

fluconazole; systemic

1.3

38.6

5511

46970

D07AB08

ATC

desonide; topical

1.5

38.5

1512

10682

P99

ICPC

Psychological disorders other

2.0

38.4

421

2128

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

38.4

157

503

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.5

38.4

247

1005

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

38.4

485

2574

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.5

38.3

204

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

38.3

1113

7396

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.6

38.3

230

906

ZX108

NOMESCO Finland

Inhalation

3.3

38.1

143

435

RS120, ,

NOMESCO Finland

6.2

38.1

106

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.6

38.0

126

354

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.4

37.9

254

1053

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

3.1

37.9

155

497

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

37.8

773

4724

J01AA02

ATC

doxycycline; systemic

1.3

37.7

12707

118500

3A422, ,

NOMESCO Finland

10.3

37.7

ZXA00

NOMESCO Finland

Right side

1.3

37.7

3786

30925

C03AA03

ATC

hydrochlorothiazide; oral

1.5

37.6

1252

8560

57199

ICD-8 Finland

Cirrhosis of liver, Unspecified

+∞

37.5

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.9

37.5

480

2559

D07AD01

ATC

clobetasol; topical

1.3

37.4

2482

19149

R16.0

ICD-10 Finland

Hepatomegaly, not elsewhere classified

13.5

37.3

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.8

37.3

189

683

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

37.3

426

2185

S29

ICPC

Skin symptom/complaint other

1.3

37.3

3054

24283

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

37.1

4177

34588

K29.8

ICD-10 Finland

Duodenitis

3.1

36.9

157

515

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.7

36.9

691

4125

M05BA04

ATC

alendronic acid; oral

1.5

36.9

1132

7609

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

36.6

631

3681

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.1

36.6

154

502

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

36.6

694

4158

P74

ICPC

Anxiety disorder/anxiety state

1.8

36.5

569

3225

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

5.0

36.5

157

L04AA05

ATC

[U] tacrolimus

9.2

36.5

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

4.6

36.5

184

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

4.5

36.5

196

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

3.8

36.4

110

290

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

36.4

3218

25839

JN1AE, ,

SPAT

1.8

36.3

568

3222

OAA67, ,

SPAT

0.7

36.3

1316

18538

M10.0

ICD-10 Finland

Idiopathic gout

1.8

36.2

545

3056

A91

ICPC

Abnormal result investigation NOS

1.6

36.2

778

4814

D05AX02

ATC

calcipotriol; topical

1.8

36.2

552

3108

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

4.3

36.1

222

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

36.1

3434

27834

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

36.1

782

4850

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

36.1

4221

35097

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

36.0

379

1890

P06

ICPC

Sleep disturbance

1.4

35.7

1862

13823

N06AX17

ATC

milnacipran; oral

2.8

35.7

181

655

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.3

35.7

265

1151

L04AA10

ATC

[U] sirolimus

13.8

35.6

K86.8

ICD-10 Finland

Other specified diseases of pancreas

4.4

35.6

204

Y90.8

ICD-10 Finland

Blood alcohol level of 240 mg/100 ml or more

6.7

35.6

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

35.5

3248

26188

R60.1

ICD-10 Finland

Generalized oedema

3.3

35.4

133

405

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

35.4

1316

9197

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

35.4

469

2529

N02BF01

ATC

gabapentin; oral

1.4

35.3

1544

11120

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.8

35.3

495

2717

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

35.2

611

3572

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

35.1

1199

8241

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

8.2

35.0

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

35.0

1035

6901

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

34.9

1335

9377

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

34.9

3097

24860

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

4.4

34.9

199

F10.8

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Other mental and behavioural disorders

7.8

34.8

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

34.8

949

6216

JAH01

NOMESCO Finland

Laparoscopy

1.7

34.8

630

3727

A10BB01

ATC

glibenclamide; oral

1.8

34.7

500

2767

A11CC03

ATC

alfacalcidol; systemic

2.0

34.7

357

1765

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.1

34.6

345

1686

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

34.6

195

745

R52.9

ICD-10 Finland

Pain, unspecified

1.4

34.5

1524

10995

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

34.4

328

1576

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

34.3

636

3788

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

34.2

1664

12205

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.0

34.2

240

V03AE01

ATC

polystyrene sulfonate; oral

2.5

34.2

217

878

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.1

34.1

347

1708

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

3.8

34.0

105

281

D07AC13

ATC

mometasone; topical

1.3

34.0

4238

35459

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

5.2

33.9

133

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

3.5

33.7

114

325

R4120

NOMESCO Finland

Occupational therapy

1.5

33.7

939

6181

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

33.6

1456

10464

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

33.6

1968

14878

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.5

33.6

116

335

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

33.6

1060

7165

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

4.8

33.5

157

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

33.5

1215

8447

57198

ICD-8 Finland

Cirrhosis of liver, Alia definita, alcoholismo non indicato

+∞

33.3

K65.9

ICD-10 Finland

Peritonitis, unspecified

5.1

33.3

139

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.5

33.2

212

860

B03XA02

ATC

darbepoetin alfa; parenteral

2.1

33.1

319

1540

WX419

NOMESCO Finland

Other general anesthesy

2.8

33.0

164

587

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

33.0

398

2081

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

5.9

32.9

101

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.3

32.9

248

1084

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

32.9

819

5253

K55.8

ICD-10 Finland

Other vascular disorders of intestine

3.9

32.9

243

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

32.7

2263

17540

P18

ICPC

Medication abuse

3.4

32.7

117

346

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

32.6

1923

14553

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

32.6

455

2495

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

32.4

1734

12917

J01CF05

ATC

flucloxacillin; systemic

1.5

32.3

1011

6820

57008

ICD-8 Finland

Acute and subacute necrosis of liver, Alii definiti

+∞

32.3

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

2.5

32.2

207

843

A10AB04

ATC

insulin lispro; parenteral

1.9

32.1

430

2326

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

32.1

854

5562

A10AB06

ATC

insulin glulisine; parenteral

2.8

32.1

165

602

N06AG02

ATC

moclobemide; oral

1.7

31.9

599

3579

ZY000

NOMESCO Finland

Hospital inpatient

2.6

31.9

183

706

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

31.9

892

5876

B01AB04

ATC

dalteparin; parenteral

1.6

31.8

715

4476

N06AX05

ATC

trazodone; oral

2.0

31.8

350

1774

R42

ICD-10 Finland

Dizziness and giddiness

1.3

31.8

3355

27492

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.1

31.7

287

1352

M79.7

ICD-10 Finland

Fibromyalgia

1.8

31.7

469

2619

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

3.4

31.6

115

344

A07AA02

ATC

nystatin; oral

1.6

31.6

794

5105

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

31.5

1532

11230

E000003, ,

ATC

1.7

31.5

585

3485

K65.8

ICD-10 Finland

Other peritonitis

5.3

31.4

120

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

2.9

31.4

149

521

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

31.3

259

1177

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.4

31.2

223

953

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

9.7

31.2

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

31.1

290

1383

3019

Kela drug reimbursment

Lenvatinib

7.9

31.1

J01MA14

ATC

moxifloxacin; systemic

1.4

31.1

1278

9097

Y07

ICD-10 Finland

Other maltreatment

3.1

30.9

125

399

212

Kela drug reimbursment

Gout

2.1

30.9

292

1400

WX290

NOMESCO Finland

Other blockage of nerve

1.2

30.8

7041

62569

5CM18, ,

NOMESCO Finland

4.2

30.8

189

D13

ICPC

Jaundice

8.1

30.7

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

30.7

626

3824

A10BH02

ATC

vildagliptin; oral

2.1

30.6

282

1338

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

30.6

817

5325

ZXA05

NOMESCO Finland

Left side

1.3

30.6

3443

28412

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

30.6

354

1826

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

30.5

291

1399

UJF02

NOMESCO Finland

Peroral enteroscopy

3.4

30.5

110

327

JN1DM

NOMESCO Finland

Upper part of abdomen very extensive MRI examination with 3 Tesla magnet

10.7

30.4

M10

ICD-10 Finland

Gout

1.6

30.4

674

4204

R03BA05

ATC

fluticasone; inhalant

1.3

30.4

2491

19754

X58

ICD-10 Finland

Exposure to other specified factors

1.3

30.3

2154

16747

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

3.9

30.3

226

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

30.3

8573

77669

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.6

30.2

175

678

K74.4

ICD-10 Finland

Secondary biliary cirrhosis

+∞

30.2

D23

ICPC

Hepatomegaly

38.1

30.2

F32.8

ICD-10 Finland

Other depressive episodes

2.3

30.1

226

987

E66.0

ICD-10 Finland

Obesity due to excess calories

2.7

30.1

166

628

A02BA03

ATC

famotidine; systemic

1.8

30.0

498

2875

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

30.0

360

1879

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

30.0

1136

7959

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

29.9

950

6428

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

29.9

1489

10959

ZZA00

NOMESCO Finland

Split skin graft

1.9

29.8

396

2138

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

29.7

10498

96969

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

3.8

29.7

243

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

29.6

1462

10742

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

29.6

453

2555

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.5

29.6

892

5970

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

2.6

29.6

168

645

D09

ICPC

Nausea

1.7

29.5

573

3456

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

5.0

29.5

127

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

29.5

496

2876

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.5

29.4

191

782

L29.9

ICD-10 Finland

Pruritus, unspecified

1.9

29.4

396

2148

L01EX08

ATC

lenvatinib; oral

7.9

29.3

K73.8

ICD-10 Finland

Other chronic hepatitis, not elsewhere classified

+∞

29.2

K77.8*D86.8

ICD-10 Finland

Hepatic granulomas in sarcoidosis

+∞

29.2

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

29.0

5348

46476

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.3

29.0

222

978

C08CA13

ATC

lercanidipine; oral

1.3

29.0

2087

16248

WX213

NOMESCO Finland

Lower leg blockade

2.7

28.9

153

567

SPAT1216

SPAT

Assessment of functional ability

1.3

28.9

2067

16078

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

28.9

781

5105

1508

Kela drug reimbursment

Lenvatinib

7.7

28.9

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.1

28.8

283

1376

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.7

28.8

484

2805

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

2.8

28.8

140

496

5714B

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]

292.5

28.8

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

28.7

686

4359

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.7

28.6

522

3097

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.5

28.5

273

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

28.5

1160

8237

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

5.2

28.5

112

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.1

28.4

255

1198

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

4.7

28.4

139

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

28.3

653

4112

J20

ICD-10 Finland

Acute bronchitis

1.4

28.2

1458

10789

WW200

NOMESCO Finland

Immunization

1.8

28.2

395

2168

M25.5

ICD-10 Finland

Pain in joint

1.2

28.2

4880

42120

WX722

NOMESCO Finland

PEEP

1.6

28.2

659

4165

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

28.1

442

2513

A97

ICPC

No disease

1.3

28.0

2864

23331

Z50.2

ICD-10 Finland

Alcohol rehabilitation

6.5

28.0

B80

ICPC

Iron deficiency anaemia

1.9

28.0

350

1853

D69.5

ICD-10 Finland

Secondary thrombocytopenia

4.3

28.0

169

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.0

28.0

290

1439

S02

ICPC

Pruritus

1.7

28.0

483

2821

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

27.9

588

3620

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

2.6

27.9

161

623

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

27.9

469

2720

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.1

27.9

265

1274

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

2.6

27.7

158

608

I50

ICD-10 Finland

Heart failure

1.8

27.7

400

2218

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.3

27.7

200

860

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

27.6

6931

61923

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

1.9

27.6

338

1778

R07.3

ICD-10 Finland

Other chest pain

1.4

27.5

1482

11039

SPAT1211

SPAT

Application of soft bandage

1.4

27.5

1143

8149

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.1

27.4

273

1335

WZC30

NOMESCO Finland

Teaching

1.3

27.4

2443

19562

D06

ICPC

Abdominal pain localized other

1.4

27.4

1222

8820

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.8

27.3

398

2212

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.1

27.3

115

376

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

27.3

270

1317

L05

ICPC

Flank/axilla symptom/complaint

1.5

27.3

902

6152

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

27.3

3135

25887

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

3.1

27.3

111

356

R05

ICPC

Cough

1.2

27.2

3591

30118

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.5

27.2

166

661

4560A

ICD-9 Finland

Varicose veins of other sites, Oesophageal varices with bleeding

53.4

27.1

RS221, ,

NOMESCO Finland

2.3

27.1

206

905

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

3.6

27.1

254

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

4.3

27.0

161

ZXE90

NOMESCO Finland

More than 22 hours

3.1

27.0

113

368

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

27.0

3284

27287

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.8

27.0

383

2112

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

26.9

3609

30309

A10BJ01

ATC

exenatide; parenteral

2.5

26.9

164

652

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

26.9

1118

7969

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

4.9

26.9

118

J01EA01

ATC

trimethoprim; systemic

1.2

26.7

3370

28117

N05BB01

ATC

hydroxyzine; systemic

1.5

26.6

778

5172

R03AC03

ATC

terbutaline; inhalant

1.3

26.6

1847

14295

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

26.6

749

4939

C09CA01

ATC

losartan; oral

1.2

26.6

3800

32127

C08CA02

ATC

felodipine; oral

1.4

26.5

1269

9269

E13

ICD-10 Finland

Other specified diabetes mellitus

4.5

26.5

143

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.4

26.4

179

748

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

26.3

853

5796

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.0

26.3

294

1500

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

3.1

26.2

110

359

SPAT1260

SPAT

Consultation of another employee

1.3

26.2

2379

19083

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

4.2

26.2

161

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.5

26.1

748

4951

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

3.1

26.1

108

350

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

26.1

2720

22195

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

26.1

3961

33692

IHZ04, ,

SPAT

2.1

26.0

234

1101

K76.5

ICD-10 Finland

Hepatic veno-occlusive disease

+∞

26.0

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.1

26.0

240

1141

SPAT1104

SPAT

Monitoring of emergency patient

1.5

26.0

866

5916

B01AB10

ATC

tinzaparin; parenteral

1.4

26.0

1540

11643

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.7

25.9

445

2595

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

3.4

25.9

276

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

25.9

1780

13758

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

25.8

291

1489

NH1AD

NOMESCO Finland

Ankle and foot CT

1.9

25.7

341

1841

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

25.6

403

2292

J01CA08

ATC

pivmecillinam; oral

1.2

25.6

5134

44850

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

25.6

1369

10183

A01AB09

ATC

miconazole; local oral

1.4

25.6

1094

7836

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.9

25.6

312

1640

X57

ICD-10 Finland

Unspecified privation

1.9

25.5

323

1718

N05AN01

ATC

lithium; oral

1.9

25.5

322

1711

IFC04, ,

SPAT

5.9

25.5

I95.9

ICD-10 Finland

Hypotension, unspecified

2.2

25.5

225

1052

TQW80

NOMESCO Finland

Local dermatologic skincare

1.8

25.4

380

2129

N03AG01

ATC

valproic acid; systemic, rectal

1.5

25.4

790

5323

Z72.0

ICD-10 Finland

Tobacco use

1.8

25.4

369

2051

A02BA04

ATC

nizatidine; systemic

1.4

25.4

993

6999

N07BA03

ATC

varenicline; oral

1.6

25.3

681

4445

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.5

25.3

740

4919

Y91.2

ICD-10 Finland

Severe alcohol intoxication

10.4

25.3

E13.4

ICD-10 Finland

Other specified diabetes mellitus, with neurological complications

10.4

25.3

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

25.3

2606

21226

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

25.3

3269

27323

E80.4

ICD-10 Finland

Gilbert syndrome

5.2

25.2

R55

ICD-10 Finland

Syncope and collapse

1.3

25.2

1516

11484

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

5.4

25.2

N03AF01

ATC

carbamazepine; oral, rectal

1.6

25.2

655

4245

N03AX14

ATC

levetiracetam; systemic

1.8

25.2

405

2320

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

25.1

629

4040

C09BA02

ATC

enalapril and diuretics; systemic

1.4

25.1

1060

7574

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

25.1

3353

28121

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

25.1

2237

17901

K76.8

ICD-10 Finland

Other specified diseases of liver

+∞

25.0

NHQ40

NOMESCO Finland

Amputation of toe

2.1

25.0

235

1126

K51

ICD-10 Finland

Ulcerative colitis

2.5

24.9

152

605

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

24.9

1587

12124

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.1

24.9

249

1220

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

4.8

24.9

118

OAA80, ,

SPAT

0.7

24.9

677

10115

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

24.8

577

3641

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

24.8

5483

48293

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

24.8

1047

7483

A29

ICPC

General symptom/complaint other

1.3

24.7

1882

14747

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.6

24.7

145

567

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

24.6

651

4233

K77

ICPC

Heart failure

1.9

24.6

301

1583

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.7

24.6

433

2543

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

24.6

741

4958

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

7.2

24.5

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.6

24.5

581

3685

P01BA02

ATC

hydroxychloroquine; oral

1.4

24.5

1072

7710

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

24.5

1116

8084

L73.2

ICD-10 Finland

Hidradenitis suppurativa

2.6

24.4

145

570

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

24.4

709

4707

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

24.4

3459

29183

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

24.4

620

3997

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

5.6

24.4

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.7

24.3

479

2900

N02AC04

ATC

dextropropoxyphene; oral

1.7

24.3

459

2748

L16

ICPC

Ankle symptom/complaint

1.3

24.3

1622

12475

M02AA07

ATC

piroxicam; topical

1.2

24.3

5131

44990

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

1.9

24.3

306

1626

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

3.3

24.3

283

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

24.2

1289

9580

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.7

24.2

445

2647

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.0

24.0

255

1279

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

23.9

813

5575

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.9

23.9

323

1755

C07AB03

ATC

atenolol; systemic

1.5

23.8

713

4764

IHZ05, ,

SPAT

1.6

23.8

492

3016

R77.0

ICD-10 Finland

Abnormality of albumin

5.9

23.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

23.8

425

2508

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.6

23.7

556

3516

D02AE01

ATC

carbamide; topical

1.5

23.7

830

5727

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.9

23.7

284

1485

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

5.0

23.7

100

K76.3

ICD-10 Finland

Infarction of liver

240.3

23.6

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

23.6

413

2422

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

6.2

23.6

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

5.2

23.5

N06AA06

ATC

trimipramine; systemic

1.9

23.5

320

1743

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.7

23.5

129

488

L30.3

ICD-10 Finland

Infective dermatitis

1.6

23.5

485

2973

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.3

23.5

264

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.2

23.4

289

A07EA02

ATC

hydrocortisone; rectal

1.9

23.4

295

1567

N05AD01

ATC

haloperidol; systemic

1.7

23.4

405

2368

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.9

23.3

288

1520

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.1

23.3

209

983

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.6

23.3

610

3958

R04.2

ICD-10 Finland

Haemoptysis

1.7

23.3

470

2865

F10.04

ICD-10 Finland

Alcohol-related acute intoxication with hallucinations

7.0

23.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.8

23.3

350

1966

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

23.3

1791

14049

D94

ICPC

Chronic enteritis/ulcerative colitis

2.7

23.2

120

440

N18.0

ICD-10 Finland

End-stage renal disease

2.5

23.1

149

609

474, ,

NOMESCO Finland

8.3

23.1

ZYD04

NOMESCO Finland

Emergency outreach service, another specialty

8.3

23.1

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

23.0

5590

49567

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

23.0

920

6510

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.2

22.9

288

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

22.9

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

2.8

22.9

112

399

I50.1

ICD-10 Finland

Left ventricular failure

1.5

22.9

645

4254

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

22.9

1261

9420

T83

ICPC

Overweight

1.9

22.9

309

1679

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

22.9

819

5674

C08CA05

ATC

nifedipine; systemic

1.5

22.9

770

5272

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.0

22.9

230

1131

L04AX03

ATC

methotrexate; systemic

1.4

22.8

1313

9874

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

4.4

22.8

131

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.4

22.8

158

668

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020191) Ethanol [Moles/volume] in Serum or Plasma

654

1256

5.37

321.55

1.8

1.4

1.04

1.33

promille

4.30

562

968

(3023520) Reticulocytes [#/volume] in Blood

2989

14560

2.26

320.75

3.0

2.6

77.87

68.98

e9/l

21.99

2192

10741

(46235355) HIV 1 and 2 tests - Meaningful Use set

4366

24715

2.01

316.03

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

865

1541

5.85

307.65

1.3

1.2

52.30

66.92

u/l

6.55

786

1335

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1019

987

10.89

307.65

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

6788

21200

4.55

307.65

1.6

1.3

595.17

487.63

titre

4.29

1732

4377

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1479

3321

4.77

307.65

5.3

6.3

3851.28

1513.37

iu/ml

0.33

200

509

(3002331) Protein [Mass/volume] in Peritoneal fluid

553

176

32.39

307.65

1.4

1.3

32.51

38.22

g/l

0.17

381

147

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4792

21323

2.70

307.65

7.6

6.3

1.05

1.04

mmol/l

2.80

4547

19917

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6737

23254

4.05

307.65

2.9

2.7

25.01

22.36

30.38

6385

21600

(3042936) Bacteria identified in Isolate by Culture

4486

23104

2.26

307.65

2.8

2.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

1159

995

12.39

307.65

1.3

1.2

268.89

124.55

titre

0.90

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3198

11210

3.26

307.65

1.4

1.5

—

(3012544) pH of Venous blood

3439

16643

2.32

307.65

5.4

4.0

7.38

0.21

2078

9542

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

551

634

8.94

307.65

1.5

1939839.60

2319220.21

iu/ml

0.19

(3044007) Cell count panel - Peritoneal fluid

656

292

23.28

307.65

2.3

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1410

2992

5.03

307.65

1.3

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

5426

2846

26.95

307.65

1.4

1.2

139.79

99.28

titre

1.34

617

235

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1505

3441

4.68

307.65

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10490

72018

2.11

307.65

10.3

6.8

1.20

1.21

mmol/l

42.01

9993

66807

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6900

25286

3.82

307.65

2.9

2.6

2.35

2.32

g/l

2.99

6447

23383

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15271

121315

2.79

307.65

18.5

8.1

105.72

78.17

u/l

307.65

14918

115395

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6603

34604

2.44

307.65

1.4

1.3

1.72

1.73

u/ml

0.01

1493

9535

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3686

15125

2.81

307.65

4.0

2.5

73.74

45.68

u/l

0.55

3228

12814

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3383

16701

2.27

307.65

3.8

4.4

14.11

28.52

ug/l

2.09

2777

13612

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6097

17934

4.64

307.65

5.4

2.5

15.75

7.77

umol/l

50.77

5549

15653

(3013650) Neutrophils [#/volume] in Blood by Automated count

12358

90722

2.18

307.65

13.3

9.9

4.14

e9/l

0.09

10966

78560

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1187

2596

4.83

307.65

2.4

3.0

7864.73

1867.68

u/ml

0.38

154

(40768441) Liver Pathology biopsy report

1583

684

25.30

307.65

1.7

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3264

6032

6.40

307.65

2.2

1.6

0.40

0.31

mg/l

9.40

1609

2988

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

677

285

24.65

307.65

2.3

1.5

9344.58

10200.21

e6/l

0.08

344

145

(3022096) Basophils/Leukocytes in Blood

11038

74564

2.26

307.65

10.1

6.7

0.71

0.68

5.86

10584

69920

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2593

11619

2.44

307.65

1.9

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3394

16368

2.33

307.65

5.3

4.0

5.64

5.83

kpa

25.06

3302

15986

(3024980) IgG subclass 4 [Mass/volume] in Serum

1338

2477

5.76

307.65

1.7

1.6

0.80

g/l

0.04

1099

1916

(3000991) Gas panel - Venous blood

2994

14369

2.30

307.65

13.2

9.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6127

15978

5.31

307.65

1.6

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2060

2091

11.01

307.65

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

1160

995

12.40

307.65

1.3

1.2

232.56

170.35

titre

1.00

176

170

(3022948) Iron [Moles/volume] in Serum or Plasma

7091

27179

3.67

307.65

3.0

2.7

13.81

13.00

umol/l

13.87

6734

25320

(3002032) Base excess in Venous blood by calculation

3324

15953

2.33

307.65

5.3

4.0

1.24

1.81

mmol/l

12.25

2863

14058

(3048929) Epstein Barr virus Ab [Presence] in Serum

1684

4373

4.15

307.65

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

7497

29742

3.62

307.65

1.8

1.5

3.26

2.36

g/l

154.90

5916

17982

(3019069) Monocytes/Leukocytes in Blood

11083

74745

2.27

307.65

10.1

6.7

9.12

8.90

11.54

10620

70175

(3013826) Glucose [Moles/volume] in Serum or Plasma

12174

93949

1.93

307.65

9.1

5.1

7.15

6.72

mmol/l

65.30

11760

89383

(3018010) Neutrophils/Leukocytes in Blood

11013

74912

2.23

307.65

9.8

6.5

57.76

57.37

2.98

10678

71635

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2000

7357

2.94

307.65

1.9

1.7

1.29

1.58

g/l

35.30

1709

6338

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7161

40984

2.25

307.65

3.1

2.3

3.15

2.80

mg/l

22.85

6428

35492

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1492

2967

5.40

307.65

1.3

42.04

56.00

u/ml

0.42

(3018418) pH of Serum or Plasma

7566

48117

1.99

307.65

5.6

4.4

7.40

6.80

5678

34315

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7278

14113

8.02

307.65

4.0

2.0

0.20

0.21

g/l

60.35

6711

13225

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1248

2731

4.84

307.65

1.3

1.5

149.30

149.77

au/ml

0.04

287

812

(3034770) Mitochondria Ab [Titer] in Serum

5284

2824

26.15

307.65

1.4

1.2

963.28

784.29

titre

0.53

262

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9323

50909

2.74

307.65

4.4

2.6

59.77

65.41

u/l

1.42

8780

47218

(3006315) Basophils [#/volume] in Blood

11705

81490

2.27

307.65

9.8

6.4

0.04

e9/l

1.42

10228

69891

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13986

83905

4.07

307.65

13.8

6.4

17.86

11.20

umol/l

130.88

13634

79965

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5416

18307

3.81

307.65

2.4

1.7

1.67

1.46

60.70

4562

16132

(3006504) Eosinophils/Leukocytes in Blood

11050

74541

2.27

307.65

10.0

6.6

2.86

2.87

0.19

10594

69939

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

2725

1380

23.12

307.65

1.1

1.55

1.47

g/l

9.04

2480

1265

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4867

24598

2.35

307.65

2.7

2.1

30.75

29.62

23.45

4729

23952

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2259

9486

2.58

307.65

5.5

4.2

23.59

24.26

mmol/l

16.49

2225

9385

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1401

2770

5.40

307.65

1.3

289.30

263.88

u/ml

2.08

853

1773

(3002030) Lymphocytes/Leukocytes in Blood

11152

76438

2.22

307.65

10.1

6.6

26.82

27.64

12.84

10769

72495

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5502

27257

2.47

307.65

4.8

3.5

0.78

0.82

mmol/l

87.52

5262

25697

(3019198) Lymphocytes [#/volume] in Blood

11802

83007

2.24

307.65

9.9

6.5

1.85

1.92

e9/l

3.74

10502

72893

(3005719) IgG [Mass/volume] in Serum or Plasma

6348

10833

8.54

307.65

2.9

11.87

10.20

g/l

118.87

5934

10034

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1386

2979

4.96

307.65

1.3

1.5

19.56

24.25

u/ml

0.53

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10700

72284

2.20

307.65

4.3

3.1

203.36

132.19

ug/l

33.66

10107

67525

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3943

18984

2.38

307.65

3.9

4.7

250.70

243.02

u/l

1.52

3738

18043

(3033658) Prothrombin time (PT) actual/Normal

8124

40594

2.84

307.65

9.7

3.9

83.96

89.94

67.95

7903

39708

(3024561) Albumin [Mass/volume] in Serum or Plasma

12833

71297

3.84

307.65

9.5

5.0

34.54

35.77

g/l

97.41

12362

66895

(40768797) Stomach Pathology biopsy report

4275

22103

2.23

307.65

1.4

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

786

330

24.87

307.65

2.4

1.5

1430.85

2826.48

e6/l

0.34

536

214

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

209

33.55

307.65

2.9

1.2

62.05

61.95

0.01

117

(3001186) Copper [Moles/volume] in Serum or Plasma

387

300

13.16

307.65

1.2

1.4

17.25

16.14

umol/l

2.58

342

263

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

1829

634

32.03

307.65

1.1

1.0

292.47

283.62

mg/l

2.05

1652

584

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2026

2135

10.58

307.65

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1924

5674

3.68

307.65

3.6

3.7

254.96

1801.56

u/ml

2.32

1670

4887

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

695

720

10.00

307.65

4.3

1.5

81.44

104.21

32.33

685

678

(3027945) Reticulocytes/Erythrocytes in Blood

3792

18779

2.29

307.65

3.1

2.6

2.10

1.75

48.41

3449

16784

(3032080) INR in Blood by Coagulation assay

12163

74068

3.01

307.65

18.2

14.8

1.24

1.26

inr

3.53

10445

61635

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

402

229

17.94

307.65

3.2

1.9

453.33

33.88

ug/l

0.86

402

229

(3023368) Bacteria identified in Blood by Culture

7473

44649

2.16

307.65

6.3

4.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

5836

8114

10.20

307.65

1.7

2.0

1.43

1.26

g/l

5.78

5401

7476

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1986

4512

4.83

307.65

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

2281

1504

17.24

307.65

3.4

2.4

749.27

510.36

u/ml

0.22

2254

1488

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11344

52923

4.13

307.65

7.1

3.1

56.10

32.01

u/l

31.87

10858

49912

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6650

19991

4.71

307.65

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1558

796

21.35

307.65

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

3062

2670

13.63

307.65

4.9

1.6

42.42

29.12

umol/l

76.23

2906

2359

(3026692) Albumin [Mass/volume] in Peritoneal fluid

651

194

34.79

307.65

1.6

1.2

10.52

16.99

g/l

19.82

467

159

(3020779) Urea [Moles/volume] in Serum or Plasma

3738

14603

2.97

307.65

10.1

7.7

10.31

9.91

mmol/l

2.33

3610

13979

(3013115) Eosinophils [#/volume] in Blood

11881

83902

2.24

307.65

10.1

6.6

0.19

0.20

e9/l

0.61

10505

73178

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11344

80486

2.12

307.65

11.3

7.4

1.20

1.21

mmol/l

47.05

9973

69712

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13966

105880

2.46

307.65

8.7

3.1

131.10

45.72

u/l

307.65

13462

99596

(3001604) Monocytes [#/volume] in Blood

11686

81260

2.27

307.65

9.8

6.4

0.60

0.59

e9/l

5.09

10214

69726

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

450

622

7.40

307.10

1.8

1.9

136.35

124.60

umol/l

0.20

197

316

(3014111) Lactate [Moles/volume] in Serum or Plasma

3010

14948

2.22

306.97

11.3

7.9

1.71

1.31

mmol/l

33.67

2945

14655

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

406

498

8.32

306.90

4.0

2.3

0.59

0.62

mmol/l

9.17

406

498

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1362

4603

3.12

306.54

3.7

2.5

3.20

3.65

g/l

19.48

1312

4406

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

533

890

6.14

303.93

1.3

1.2

122.81

83.74

u/l

7.05

484

740

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

521

873

6.12

296.00

1.3

1.2

34.57

21.20

u/l

3.72

465

712

(3044640) Blood type and Crossmatch panel - Blood

7479

51213

1.79

294.77

3.6

2.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9656

71310

1.77

292.36

3.4

2.4

73.59

1341.75

nmol/l

0.50

8966

64858

(4281824) Cell count and differential, peritoneal fluid

679

1474

4.75

289.23

1.4

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1086

3317

3.42

288.27

3.3

3.6

777.09

747.82

u/ml

0.02

988

3017

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4545

26811

1.93

287.75

2.2

1.9

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

174

39.04

284.99

2.8

1.2

14.44

20.26

0.52

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1317

4566

3.03

282.96

2.1

1.7

—

(3026782) Osmolality of Urine

4972

30501

1.87

277.40

3.4

3.0

506.99

538.36

mosm/kgh2o

19.71

4448

26814

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

487

851

5.85

264.85

1.7

1.5

6.57

7.10

u/l

0.26

380

683

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9447

70523

1.72

264.09

2.6

2.1

94.81

96.13

pmol/l

1.84

5391

37864

(3020630) Protein [Mass/volume] in Serum or Plasma

2708

13647

2.16

262.74

2.2

2.7

66.44

66.35

g/l

0.20

2477

12581

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2881

14915

2.11

260.47

2.3

2.4

367.00

376.70

nmol/l

1.33

2696

13891

(3030467) Casts [#/volume] in Urine by Automated count

6680

45463

1.75

259.57

4.1

3.4

0.60

0.41

e6/l

6.19

5057

33310

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2306

11018

2.25

254.91

11.6

8.3

24.05

24.88

mmol/l

18.66

2283

10945

(36304419) Bacteria [Presence] in Urine

6395

43158

1.75

254.81

4.0

3.3

0.26

232.21

estimate

0.84

189

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1658

6883

2.55

251.27

1.5

1.6

9.16

15.22

iu/ml

1.28

175

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1477

5809

2.68

249.85

1.4

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

7458

52752

1.71

249.24

4.2

3.5

82.47

84.64

e6/l

0.03

5822

40334

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1235

4491

2.88

242.53

1.6

1.5

13.08

13.77

iu/ml

0.06

(3019977) pH of Arterial blood

3440

19454

1.95

241.25

11.8

7.9

7.42

0.00

1793

10517

(3027801) Oxygen [Partial pressure] in Arterial blood

3436

19453

1.95

240.04

11.8

7.9

11.78

12.45

kpa

13.91

3318

18746

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1313

4963

2.78

239.68

4.8

3.3

1.70

1.53

mg/l

9.13

1234

4527

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3435

19465

1.95

239.24

11.8

7.9

4.93

5.10

kpa

20.02

3313

18778

(3021589) Normoblasts [#/volume] in Blood

9290

70213

1.67

237.61

18.6

11.6

0.00

e9/l

0.36

7587

57140

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5844

39061

1.74

236.87

3.5

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

2638

13673

2.09

235.82

4.5

3.3

4.73

4.54

kpa

4.21

2548

13323

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1619

6842

2.50

235.69

2.0

44.31

39.15

u/l

14.09

1461

6080

(3019309) Folate [Moles/volume] in Red Blood Cells

4290

26244

1.84

235.04

1.9

1.7

1173.86

1149.60

nmol/l

0.90

3365

20101

(3009508) Creatinine [Moles/volume] in Urine

7861

57013

1.68

234.56

4.2

3.5

7.33

7.73

mmol/l

12.99

6748

48292

(3003396) Base excess in Arterial blood by calculation

3401

19325

1.94

234.43

11.7

7.8

0.31

0.96

mmol/l

12.79

2836

16083

(36660697) Celiac disease serology panel - Serum

2411

12143

2.14

232.15

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1288

4904

2.75

231.64

1.5

1.4

260.91

270.72

ug/g

0.78

764

2892

(3021960) Folate [Moles/volume] in Serum or Plasma

6520

45309

1.69

226.62

2.0

1.7

19.17

20.07

nmol/l

5.22

5814

38543

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3455

19937

1.91

226.44

2.1

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

507

1059

4.90

225.86

1.2

1.3

84.95

84.50

0.06

(3020682) Albumin/Creatinine [Ratio] in Urine

7561

54695

1.66

224.81

5.0

4.2

12.35

8.15

mg/mmol

7.74

5073

34163

(3018095) Leukocytes [#/volume] in Urine

8094

59662

1.65

222.95

5.1

4.0

96.51

95.88

e6/l

0.02

5982

42367

(3016502) Oxygen saturation in Arterial blood

3099

17357

1.95

221.63

12.4

8.2

95.48

95.61

0.52

3013

16793

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7045

50306

1.66

218.43

2.7

2.2

239.51

212.20

u/l

0.91

6727

47598

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3265

18694

1.91

218.25

2.1

1.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1242

4849

2.68

212.16

3.1

2.2

79.90

93.60

45.99

1203

4680

(3026250) Tacrolimus [Mass/volume] in Blood

399

712

5.71

212.09

41.9

40.1

6.83

7.42

ug/l

6.02

362

641

(3009343) pH of Capillary blood

2125

10589

2.14

208.91

4.5

3.6

7.41

7.42

2.10

1847

8770

(3023420) DNA double strand Ab [Units/volume] in Serum

1506

6529

2.43

206.38

1.9

1.8

7.85

7.04

iu/ml

0.33

309

1556

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2165

10921

2.12

206.01

4.5

3.6

5.00

5.16

kpa

14.72

2087

10408

(3012516) Albumin [Mass/volume] in Urine

7370

53803

1.63

205.52

4.1

3.5

65.40

46.17

mg/l

8.00

5124

34375

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2037

10095

2.15

202.76

14.0

9.7

23.77

24.32

mmol/l

8.94

1989

9888

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

454

946

4.90

202.74

1.6

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

418

818

5.21

200.76

1.2

1.1

106.89

79.92

u/l

6.58

373

737

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1901

9204

2.19

200.64

4.4

3.5

1.42

1.80

mmol/l

3.58

1379

6829

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

13615

116073

1.73

200.00

6.5

4.4

17.24

11.79

mm/h

228.67

12953

108869

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

414

810

5.21

198.88

1.2

1.1

33.62

23.77

u/l

2.18

368

727

(3048689) Calprotectin [Mass/mass] in Stool

3366

20024

1.84

197.35

3.4

2.4

147.82

137.96

ug/g

0.96

2845

15963

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2866

16223

1.91

196.28

13.2

8.7

116.37

122.16

g/l

36.51

2808

15876

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4128

26162

1.75

195.13

3.6

3.2

3.03

2.31

e6/l

3.00

2054

12736

(3042733) HLA Ab [Presence] in Serum

320

501

6.49

194.26

2.5

5.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9413

73645

1.59

191.50

3.9

2.8

—

estimate

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

980

3604

2.82

187.43

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

357

649

5.59

185.98

34.4

28.1

121.50

112.96

ug/l

1.28

298

523

(3031040) Bacteria [#/volume] in Urine by Automated count

12133

101315

1.62

182.89

5.9

4.6

1129.60

1760.95

e6/l

0.77

168

1444

(3007853) Bacteria identified in Skin by Aerobe culture

3187

19068

1.82

181.73

2.0

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

5286

36371

1.64

181.28

3.3

2.8

6.29

4.95

e6/l

9.11

4845

33200

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1114

4455

2.60

180.59

3.1

2.5

213.78

193.02

9.34

1066

4256

(3026493) Urate [Moles/volume] in Serum or Plasma

6151

43981

1.61

180.11

3.5

2.8

364.08

344.62

umol/l

34.68

5456

38912

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2263

12184

1.98

178.39

4.7

4.1

92.72

91.48

ng/l

0.24

2002

10565

(3003181) Sodium [Moles/volume] in Urine

824

2846

2.99

176.61

1.5

1.4

54.76

63.00

mmol/l

6.37

601

2287

(3002179) Metamyelocytes/Leukocytes in Blood

2495

13951

1.92

175.69

5.2

4.3

0.68

0.74

0.42

962

4275

(3017181) Myelocytes/Leukocytes in Blood

2585

14657

1.89

174.33

5.4

4.5

0.79

0.98

3.58

1011

4486

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1346

5975

2.35

173.89

2.6

2.3

815.15

579.92

ug/l

1.05

1273

5674

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5072

35079

1.62

167.70

2.2

1.8

1.62

1.19

mg/l

12.44

4136

27331

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1869

9641

2.05

165.42

1.9

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4316

28754

1.66

165.25

3.5

3.1

1.31

1.16

e6/l

0.44

2248

15383

(3037467) Urinalysis macro (dipstick) panel - Urine

12506

106350

1.59

163.31

5.9

4.5

0.82

2.31

—

169

(3036489) Thrombin time

1301

5856

2.32

162.43

2.8

2.1

22.44

20.97

8.96

1183

5180

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6534

48243

1.56

162.08

3.8

3.2

1764.25

1321.96

ng/l

7.12

5588

41617

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

255

381

6.78

161.86

1.5

1.7

11.23

8.75

ug/l

8.23

255

381

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1217

5339

2.37

161.16

3.5

3.2

0.31

0.35

iu/ml

4.98

648

2948

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

270

433

6.32

160.07

1.1

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1855

9711

2.02

157.18

14.3

10.2

15.33

16.17

26.98

1801

9397

(3022145) Colonoscopy Study observation

3070

18886

1.76

156.77

1.6

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

2438

14011

1.86

156.25

5.5

4.5

0.08

0.12

0.93

863

3853

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1103

4707

2.43

155.23

1.4

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2038

11156

1.93

151.44

15.2

10.0

93.69

94.00

1.41

2028

11122

(3025159) Blasts/Leukocytes in Blood

2440

14170

1.84

150.80

5.7

4.7

0.12

0.32

1.39

813

3706

(40758558) Short blood count panel - Blood

6455

48154

1.53

149.44

8.9

6.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1979

10774

1.94

149.34

15.5

10.1

0.61

0.64

1.78

1969

10712

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

833

3179

2.70

147.79

1.6

2.0

0.99

0.85

nmol/l

5.99

699

2709

(3034274) Bile acid [Moles/volume] in Serum --fasting

460

1250

3.75

144.79

3.2

1.9

21.35

7.68

umol/l

9.70

384

900

(3024932) HLA-DR beta [Type]

268

472

5.75

144.39

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

535

1610

3.39

144.25

1.3

1.4

7.84

6.62

g/l

6.32

365

1176

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1516

7599

2.09

144.11

1.1

4.32

8.72

u/ml

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2010

11135

1.91

143.61

15.2

9.8

1.44

1.32

6.18

2000

11068

(3024471) HLA-A [Type]

271

485

5.66

143.54

1.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

532

1609

3.38

142.29

1.3

1.4

3.10

2.90

g/l

1.47

362

1178

(3024139) IgG subclass 3 [Mass/volume] in Serum

532

1609

3.38

142.29

1.3

1.4

0.50

0.41

g/l

1.91

360

1175

(4062490) Immunoglobulin typing, IgG

524

1580

3.39

140.83

1.3

1.4

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

110

18.44

138.31

1.1

1.3

1324.66

656.98

u/l

0.35

100

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

914

3787

2.49

136.82

1.3

6.99

4.42

u/ml

0.27

253

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4480

31442

1.57

133.37

4.9

4.0

309.21

483.32

ng/l

2.73

3594

24695

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1018

4491

2.34

132.48

1.3

13.07

4.33

u/ml

1.07

114

419

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1066

4799

2.30

132.33

1.3

41.01

39.68

u/ml

0.05

245

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1336

6589

2.11

132.17

2.3

2.0

2.26

2.12

ug/l

0.20

1216

5882

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1013

4483

2.34

130.84

1.4

1.3

6.08

7.03

u/ml

0.27

151

653

(3015377) Calcium [Moles/volume] in Serum or Plasma

7097

55096

1.48

130.11

3.8

3.6

2.34

2.36

mmol/l

8.71

6526

50186

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

470

1425

3.36

125.16

1.8

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2548

15835

1.71

122.55

4.4

3.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

738

2918

2.59

121.66

1.2

298.11

289.09

titre

0.04

220

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1326

6730

2.05

121.11

1.8

2.5

4.35

4.21

g/l

4.69

1191

6199

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1327

6742

2.05

120.85

1.8

2.5

7.32

7.35

g/l

0.33

1190

6200

(3004119) Hemoglobin [Mass/volume] in Venous blood

1808

10205

1.86

120.69

4.5

3.4

123.34

129.97

g/l

24.33

1756

9923

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1323

6718

2.05

120.66

1.8

2.5

4.01

3.69

g/l

9.01

1189

6183

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

736

2937

2.57

119.03

1.2

42.50

150.67

titre

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1260

6352

2.06

117.10

1.9

2.5

2.90

2.88

g/l

0.46

1126

5814

(4035726) Immunohistochemistry procedure

2291

13994

1.73

116.89

1.5

1.4

—

(1616796) Gas panel - Central venous blood

843

3635

2.38

115.28

4.3

3.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

148

178

8.38

113.60

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1166

5787

2.09

112.91

1.9

2.6

0.50

0.85

g/l

4.43

997

5000

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1167

5822

2.07

111.41

5.1

3.8

24.38

24.88

mmol/l

5.92

1101

5349

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

898

4043

2.29

111.08

1.3

10.47

11.66

u/ml

—

(3028626) Oxygen [Partial pressure] in Capillary blood

906

4098

2.28

110.84

3.9

3.3

8.33

8.20

kpa

1.37

886

3999

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1013

4798

2.18

110.69

1.8

1.7

0.23

0.24

g/l

2.40

957

4584

(3034860) Kappa light chains.free [Mass/volume] in Serum

1139

5648

2.09

110.50

2.3

3.5

58.97

61.73

mg/l

0.10

938

4803

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1138

5646

2.08

110.24

2.3

3.5

46.23

43.31

mg/l

0.35

936

4803

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

397

1172

3.44

110.24

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1205

6108

2.04

110.13

1.3

1.2

0.93

1.01

u/ml

0.07

527

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

448

1431

3.19

109.52

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

796

3425

2.39

109.30

1.7

1.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

390

1146

3.46

109.08

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

478

1591

3.06

108.94

2.3

2.4

31.17

24.03

iu/ml

0.70

176

(40759836) Histone Ab [Presence] in Serum by Immunoblot

410

1249

3.34

108.32

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

415

1275

3.31

108.16

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

539

1930

2.85

107.73

1.3

63.19

61.84

u/ml

0.04

124

(3024928) Oxygen saturation in Venous blood

908

4161

2.25

107.60

4.0

3.4

62.50

62.08

0.21

860

4040

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7623

61428

1.42

107.59

5.0

3.7

56.73

70.92

ng/l

0.47

5728

42997

(3033942) Copper [Moles/time] in 24 hour Urine

20.86

107.54

1.4

1.2

1.09

1.17

umol/24h

0.03

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

403

1226

3.34

106.71

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

403

1229

3.33

106.29

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1143

5780

2.04

105.01

1.8

2.4

11.72

9.99

g/l

21.22

1002

5179

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1014

4914

2.13

104.37

1.8

2.5

0.01

0.03

g/l

2.52

894

4428

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1147

5821

2.04

104.33

3.2

3.0

23.97

24.81

mmol/l

9.15

1123

5724

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1019

4951

2.12

104.18

1.8

1.7

1.21

1.20

g/l

0.52

966

4747

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

391

1195

3.32

102.76

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

199

368

5.46

101.79

1.1

1.2

1104.55

996.34

titre

0.46

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

978

4725

2.13

101.41

1.9

2.5

0.00

g/l

0.23

845

4147

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

928

4404

2.17

100.73

1.9

2.5

0.00

g/l

-0.00

844

4135

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1021

5030

2.09

100.56

2.3

3.4

2.52

4.40

ratio

1.14

566

2884

(3000494) Fungus identified in Specimen by Culture

2952

19922

1.58

100.28

1.8

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4468

32975

1.47

99.49

1.9

1.7

28844048.77

32401428.99

pmol/l

0.15

3727

27601

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

786

3505

2.30

99.29

1.3

1.2

52.16

43.60

u/ml

0.57

328

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

592

2320

2.60

99.22

6.8

6.3

12.08

11.70

mg/l

1.13

545

2154

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

13.85

98.74

2.4

2.2

—

(3015736) pH of Urine

8160

67426

1.39

95.13

4.0

3.4

6.17

6.20

1.49

4371

37700

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

463

1640

2.87

94.38

1.4

1.3

1.55

1.44

nmol/l

1.05

421

1465

(3035350) Ketones [Presence] in Urine by Test strip

9871

84369

1.38

92.39

4.7

3.9

13.80

3.93

estimate

3.20

2416

17355

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2010

12586

1.67

92.01

5.0

4.0

1.22

1.23

mmol/l

8.44

1833

10853

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

603

2473

2.49

91.86

1.1

386.05

4916.34

iu/ml

0.52

105

506

(3021601) Nitrite [Presence] in Urine by Test strip

9768

83399

1.38

91.72

4.7

3.8

0.00

estimate

0.06

2381

16970

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

562

2231

2.57

91.69

1.2

16.11

10.60

u/ml

0.33

(3009261) Glucose [Presence] in Urine by Test strip

9918

84920

1.38

91.33

4.8

3.9

1.39

0.24

estimate

0.83

2209

16324

(3010421) pH of Blood

1005

5126

2.02

89.84

4.8

3.7

7.41

1.36

985

5062

(3000093) Morphology [Interpretation] in Blood Narrative

428

1502

2.89

88.74

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1002

5129

2.01

88.65

1.7

1.6

18.22

4.00

iu/ml

0.37

185

974

(3028707) Methadone [Presence] in Urine by Screen method

555

2226

2.54

88.62

3.8

2.7

—

(3021901) Oxygen saturation in Capillary blood

747

3419

2.24

88.55

3.3

3.1

90.25

89.90

0.72

727

3327

(3012501) Base excess in Blood by calculation

737

3358

2.25

88.33

5.1

4.0

2.53

mmol/l

0.02

504

2294

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

125

166

7.58

88.32

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

899

4431

2.08

88.22

4.0

3.2

2.44

2.20

index

0.28

503

2269

(3013290) Carbon dioxide [Partial pressure] in Blood

737

3360

2.24

88.20

5.1

4.0

4.84

5.02

kpa

7.73

715

3290

(3027315) Oxygen [Partial pressure] in Blood

740

3383

2.24

87.96

5.1

4.0

8.62

8.63

kpa

0.01

718

3312

(3037756) Immunofixation for Serum or Plasma

739

3398

2.23

86.60

1.4

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

736

3383

2.23

86.32

3.3

2.7

15.77

16.54

8.55

719

3313

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

884

4458

2.03

81.41

2.2

2.1

12.04

11.66

mg/l

0.59

829

4172

(3017732) Neutrophils [#/volume] in Blood

2908

20494

1.50

78.92

3.4

3.3

4.71

4.47

e9/l

0.80

2544

17768

(3027273) Bicarbonate [Moles/volume] in Venous blood

1275

7332

1.80

78.66

4.6

3.5

24.70

25.24

mmol/l

5.75

1230

7097

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

742

3568

2.13

77.58

1.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

199

487

4.12

72.59

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1924

12615

1.59

72.02

3.5

3.0

248.63

193.75

ng/l

3.06

1754

11547

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

890

4701

1.94

71.65

1.4

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4122

31522

1.40

71.26

3.2

3.1

2.47

2.45

mmol/l

16.71

3633

28314

(3028271) Lactate [Moles/volume] in Capillary blood

561

2499

2.29

70.87

2.4

1.9

1.86

1.71

mmol/l

2.41

545

2436

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

643

3047

2.15

69.76

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

643

3047

2.15

69.76

1.4

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1336

8146

1.69

66.61

5.4

4.0

48.41

47.78

0.39

1315

8037

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1234

7385

1.72

65.88

7.1

5.0

1.80

1.63

4.92

1166

7017

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

802

4215

1.95

65.45

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

5554

45005

1.34

65.44

3.4

2.9

0.09

0.07

0.17

105

1024

(3037121) Protein [Mass/volume] in Urine

960

5370

1.83

64.59

3.7

3.4

416.21

474.87

mg/l

0.32

518

2448

(4198724) Urine methamphetamine measurement

207

576

3.62

63.02

3.0

1.9

—

(3025941) Bacteria identified in Stool by Culture

1356

8445

1.66

62.20

1.3

1.2

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

8.30

61.93

1.2

1.3

1.45

1.16

ml/s/173m2

0.97

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1581

10278

1.59

60.83

9.8

7.1

23.70

24.58

mmol/l

12.99

1518

9862

(3004347) Hepatitis D virus Ab [Presence] in Serum

16.50

60.71

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

293

1041

2.84

59.45

1.3

1.2

31.81

34.81

mmol/l

1.50

263

905

(40761536) Microorganisms panel - Urine sediment

1816

12249

1.54

59.30

5.0

4.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1120

6722

1.71

59.00

7.4

5.3

0.87

0.88

0.54

1055

6373

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

308

1134

2.75

58.43

1.6

1.4

13.77

12.73

umol/l

1.33

294

1070

(3008295) Osmolality of Serum or Plasma

410

1734

2.40

58.36

1.3

1.4

275.86

278.79

mosm/kgh2o

1.45

317

1331

(3006184) Hemoglobin [Mass/volume] in Capillary blood

742

3953

1.92

58.08

2.7

2.3

124.69

130.51

g/l

7.43

582

3002

(3022806) Fractional oxyhemoglobin in Capillary blood

429

1864

2.33

57.44

2.3

1.8

89.68

89.56

0.15

423

1835

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

797

4366

1.86

57.23

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

719

3826

1.92

56.46

1.1

6.92

6.85

eliau/ml

0.01

499

(3000012) Reticulocyte production index

499

2333

2.17

55.99

2.5

2.1

1.02

0.90

2.73

380

1571

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

983

5794

1.74

55.20

2.5

2.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1005

5966

1.73

55.01

1.6

18.80

18.69

u/ml

0.02

171

1415

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

179

505

3.57

53.44

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

551

2735

2.05

52.83

3.1

3.6

1.48

1.65

0.51

503

2470

(3011288) Drugs identified in Urine by Screen method Nominal

679

3637

1.90

52.24

4.8

2.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

229

763

3.03

52.21

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

229

763

3.03

52.21

1.6

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1141

7119

1.64

51.68

1.1

116.75

184.08

titre

1.24

199

(21494755) Public health laboratory ask at order entry panel

886

14595

0.59

51.27

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4737

38557

1.31

51.17

4.2

3.8

0.36

0.32

0.07

377

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

118

6.72

50.29

1.6

1.4

—

(3019225) pH of Specimen

2099

15050

1.45

50.13

5.9

4.3

7.37

7.36

2.38

1726

10870

(3027974) Hepatitis B virus e Ag [Presence] in Serum

8.54

49.34

1.3

1.7

—

(3047181) Lactate [Moles/volume] in Blood

843

4910

1.75

49.30

7.8

5.9

1.65

1.31

mmol/l

8.32

726

4366

(1001926) Buprenorphine [Presence] in Urine by Screen method

740

4153

1.82

49.09

3.3

2.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.67

48.72

1.2

45.85

47.20

mg/l

0.07

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

191

598

3.22

48.43

2.3

1.9

18004.97

42005.61

u/ml

0.46

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

559

2883

1.97

48.13

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

434

2044

2.15

47.82

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

222

769

2.91

47.28

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

527

2689

1.99

46.79

1.2

1.17

0.89

0.32

100

(3008757) Leukocyte morphology finding [Identifier] in Blood

365

1621

2.28

46.48

3.1

3.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

207

698

2.99

46.27

3.4

5.1

98.78

1257.55

mg/l

1.29

167

507

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

192

621

3.11

46.13

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

230

838

2.77

44.62

2.9

3.3

34.53

26.63

mu/l

1.38

217

794

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

118

287

4.13

43.56

1.5

1.3

768.75

3523.45

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

8.08

43.45

1.3

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

204

714

2.88

42.68

3.0

1.6

25.98

29.35

umol/l

3.32

198

671

(3003434) Protein [Mass/volume] in Pleural fluid

448

2230

2.03

42.65

1.7

1.4

97.62

33.62

g/l

0.46

402

2030

(3027923) C peptide [Moles/volume] in Serum or Plasma

246

951

2.61

42.50

1.4

1.34

1.22

nmol/l

0.79

181

710

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

367

1697

2.19

42.40

1.2

55.12

39.26

u/ml

0.61

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

650

3666

1.80

42.39

2.3

2.4

153.28

109.74

ug/min

1.14

385

2205

(1761868) Lipid panel - Serum or Plasma

5249

61522

0.79

41.39

3.8

3.2

—

(3038026) Centromere Ab [Units/volume] in Serum

288

1216

2.39

41.25

1.2

52.92

47.00

u/ml

0.14

(3000963) Hemoglobin [Mass/volume] in Blood

16035

165393

0.70

40.99

47.2

24.7

131.34

136.20

g/l

237.18

15919

163773

(3026361) Erythrocytes [#/volume] in Blood

16032

165364

0.70

40.93

46.7

24.5

4.36

4.52

e12/l

210.11

15766

161517

(3010813) Leukocytes [#/volume] in Blood

16034

165381

0.70

40.93

46.8

24.5

6.96

6.72

e9/l

29.03

15777

161521

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

725

4273

1.73

40.59

1.3

213.61

219.23

miu/ml

0.14

229

1851

(3035941) MCH [Entitic mass]

16032

165342

0.70

40.53

46.6

24.4

30.56

30.36

27.61

15911

163687

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16035

165356

0.70

40.32

48.2

25.0

39.36

41.05

45.82

15907

163633

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16034

165344

0.70

40.26

46.6

24.4

91.83

91.15

52.58

15913

163686

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3656

29535

1.30

40.01

1.4

1.3

39.52

33.56

iu/ml

1.08

1139

9062

(3018405) Lactate [Moles/volume] in Arterial blood

860

5329

1.64

39.85

5.6

4.2

1.79

1.37

mmol/l

8.77

840

5231

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

359

1688

2.15

39.78

1.2

1.1

0.83

1.94

iu/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

512

2741

1.89

39.46

1.5

1.6

—

(3007461) Platelets [#/volume] in Blood

16034

165294

0.71

39.36

46.8

24.5

234.94

250.17

e9/l

116.25

15811

162008

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

416

2076

2.03

39.35

1.6

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3402

27328

1.30

38.66

1.4

1.3

9.99

11.96

u/ml

0.90

1130

10764

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

501

2685

1.89

38.49

1.2

1.4

3.36

12.90

u/ml

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

196

711

2.78

38.41

3.1

1.7

1.74

1.98

umol/l

3.03

189

652

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

963

6201

1.58

38.08

2.2

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

696

4128

1.71

38.08

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

699

4156

1.71

37.90

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

203

4.50

37.61

1.6

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

699

4166

1.71

37.57

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

896

5690

1.61

37.56

2.0

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

417

2124

1.99

37.26

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

405

2050

2.00

36.84

1.5

1.4

—

(3020891) Body temperature

1155

7801

1.51

36.80

6.5

4.7

36.94

36.91

°c

2.14

1144

7727

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

648

3808

1.73

36.66

1.5

—

(3044927) Protein electrophoresis panel - Urine

323

1509

2.16

36.41

1.2

—

(3016879) Cocaine [Presence] in Urine

806

5028

1.63

36.34

3.4

2.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

236

967

2.46

36.17

3.2

2.6

1340.25

1043.86

u/ml

0.86

236

953

(3024522) Salmonella sp identified in Specimen by Organism specific culture

397

2009

2.00

36.14

1.5

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

310

1430

2.19

36.09

1.2

65.69

85.51

u/ml

0.54

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

241

1000

2.43

35.94

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

396

2007

2.00

35.90

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

237

981

2.43

35.54

1.4

—

(3002256) Pathology report gross observation

2734

21535

1.32

35.53

1.4

1.3

—

(21494434) Karyotype in Bone marrow

302

1388

2.20

35.48

1.2

—

(3042631) Mycobacterium sp identified in Specimen

420

2186

1.94

35.26

2.6

2.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

381

1920

2.01

35.11

1.5

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1802

13345

1.39

35.06

3.3

2.7

60.99

67.03

ml/min/173m2

7.28

799

5587

(3005988) Vibrio sp identified in Specimen by Organism specific culture

381

1923

2.00

34.95

1.5

1.4

—

(40768806) Pleura Pathology biopsy report

344

1675

2.07

34.84

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

377

1911

1.99

34.18

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

471

2577

1.85

33.94

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

403

2096

1.94

33.92

2.3

2.5

1.22

1.27

g/24h

0.18

256

1225

(3028308) Erythrocytes [#/volume] in Pleural fluid

352

1748

2.03

33.80

1.7

1.4

41001.57

52619.21

e6/l

0.49

198

985

(3000764) Benzodiazepines [Presence] in Urine

838

5371

1.59

33.76

3.3

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5233

44845

1.24

33.74

4.3

3.3

0.72

0.19

estimate

1.17

1987

13467

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

557

3215

1.76

33.59

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

842

5414

1.58

33.46

3.4

2.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1209

17040

0.69

33.26

2.0

3.79

3.52

ratio

6.96

952

13345

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

244

1055

2.33

33.21

2.0

1.8

—

(3027008) Opiates [Presence] in Urine

839

5400

1.58

33.20

3.0

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

322

1558

2.09

33.18

4.2

3.4

15.61

13.44

index

1.59

223

871

(40768443) Skin Pathology biopsy report

1086

7408

1.50

32.92

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3917

46558

0.80

32.74

4.0

4.5

22.58

21.99

1.33

1686

22709

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12685

118957

1.23

32.26

5.1

4.3

14.78

pmol/l

0.06

11756

109577

(3023199) Leukocytes [#/volume] in Pleural fluid

380

1975

1.94

32.07

1.7

1.5

8300.88

2870.42

e6/l

0.95

257

1387

(3011985) Renin [Units/volume] in Plasma

445

2437

1.85

31.99

1.7

1.5

89.93

64.73

mu/l

1.19

401

2177

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

827

12448

0.65

31.72

1.7

3.50

3.49

mmol/l

0.11

573

8676

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

513

2940

1.77

31.72

1.3

32.97

31.13

u/l

0.14

457

2538

(3014148) Varicella zoster virus Ab [Titer] in Serum

383

2013

1.92

31.28

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

515

2972

1.75

31.09

3.3

3.2

0.81

nmol/l

0.05

388

2383

(3029937) Albumin [Presence] in Urine by Test strip

5356

46317

1.22

31.03

5.0

4.1

0.00

estimate

0.41

2155

15583

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

547

3217

1.72

30.88

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

305

1487

2.07

30.83

3.4

2.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

343

1757

1.97

30.23

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

269

1261

2.15

30.15

1.3

11.47

8.95

mmol/l

9.58

244

1180

(3017354) Segmented neutrophils/Leukocytes in Blood

345

1773

1.96

30.12

3.0

3.6

58.86

57.45

0.61

304

1534

(3036782) Glucose [Moles/volume] in Pleural fluid

316

1578

2.02

29.93

1.5

1.3

6.68

6.28

mmol/l

1.62

295

1456

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

148

530

2.81

29.83

3.4

3.7

8.43

8.28

mg/l

0.09

114

429

(3027944) Amphetamines [Presence] in Urine

814

5332

1.55

29.80

3.3

1.9

—

(3039000) Anion gap in Blood by calculation

561

3358

1.69

29.69

10.0

7.0

12.11

11.24

mmol/l

5.56

506

3037

(3018572) Chloride [Moles/volume] in Blood

561

3359

1.69

29.66

10.0

7.0

104.39

105.08

mmol/l

2.06

506

3039

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1351

9801

1.41

29.47

3.3

3.5

4.38

4.47

pmol/l

2.58

1206

8815

(3005322) IgE [Units/volume] in Serum or Plasma

1406

10289

1.40

29.15

1.4

1.3

288.73

252.57

u/ml

0.41

1324

9573

(3040151) Glucose [Moles/volume] in Capillary blood

354

1860

1.92

28.97

25.5

6.2

8.04

7.49

mmol/l

0.66

297

1548

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

306

1532

2.01

28.80

1.4

1.3

661.79

490.13

u/l

0.40

285

1458

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

409

2256

1.83

28.77

1.3

354.31

353.46

pmol/l

0.01

356

1912

(44790048) Parainfluenza type 2 nucleic acid detection

389

2122

1.85

28.36

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

389

2122

1.85

28.36

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

389

2122

1.85

28.36

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

389

2122

1.85

28.36

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

617

3843

1.63

27.99

4.3

3.1

1.87

1.57

mmol/l

5.41

602

3741

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15753

152029

1.31

27.89

31.7

16.2

22.45

24.97

mg/l

24.31

14618

125475

(3035947) Staphylolysin Ab [Units/volume] in Serum

184

765

2.42

27.44

1.2

1.1

3.14

3.92

iu/ml

0.60

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1775

13616

1.34

27.23

2.6

2.3

8.24

7.81

ug/l

0.27

1546

12044

(3045788) Cell count panel - Pleural fluid

311

1600

1.96

27.11

1.7

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

122

415

2.95

27.06

1.2

1.1

—

(3013512) EKG study

6248

55398

1.20

26.83

4.4

3.6

0.62

0.78

0.54

147

(40762365) Oxygen content in Arterial blood by calculation

242

3.61

26.76

3.0

3.1

14.20

14.90

ml/dl

1.22

226

(3003327) Ova and parasites identified in Stool by Light microscopy

835

5635

1.51

26.61

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

633

4017

1.60

26.60

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

146

557

2.63

26.10

1.1

1.2

0.29

0.18

g/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

322

1701

1.91

25.97

1.5

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

259

1269

2.06

25.91

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

172

714

2.42

25.77

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

172

714

2.42

25.77

1.5

1.4

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.84

25.64

2.2

1.4

205.92

173.31

ug/g

0.46

(3042517) Benzodiazepines panel - Urine

143

4.42

25.59

3.2

3.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

359

1985

1.83

25.11

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

161

664

2.44

24.50

3.7

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2900

34726

0.80

24.48

3.0

3.2

0.72

0.76

ug/l

1.29

1922

22496

(3009871) Measles virus Ab [Titer] in Serum

158

648

2.45

24.34

1.6

4051.43

2991.52

titre

0.88

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

583

3711

1.59

24.21

2.4

2.2

4184.08

4845.26

u/l

0.22

187

1375

(21494815) CD4 cells/Lymphocytes in Specimen

274

1413

1.95

23.78

2.3

39.20

38.56

0.26

267

1389

(3011412) CD3 cells [#/volume] in Blood

293

1553

1.90

23.44

2.1

2.5

1155.79

1172.64

e6/l

0.12

255

1370

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

239

1182

2.04

23.36

1.6

1.4

17.26

12.49

u/l

9.76

229

1143

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

407

2389

1.72

23.22

1.4

1.2

3.87

3.84

u/ml

0.02

212

1119

(3017315) Amylase [Enzymatic activity/volume] in Urine

186

850

2.20

22.36

1.5

1.2

487.21

345.96

u/l

0.36

170

787

(3051339) Copper [Moles/volume] in Blood

5.45

22.36

1.6

1.1

16.16

16.58

umol/l

0.18

(3038515) Glucose [Moles/volume] in Venous blood

508

3194

1.61

22.24

4.5

3.2

7.95

7.60

mmol/l

1.59

495

3111

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

133

528

2.53

22.00

2.5

2.0

8.84

9.13

mg/l

0.24

105

449

(3010838) Calcium [Moles/time] in 24 hour Urine

474

2941

1.63

21.91

1.9

5.10

5.12

mmol/24h

0.03

424

2633

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

108

387

2.80

21.88

1.9

1.7

188.79

95.52

au/ml

0.90

(3013139) Helicobacter pylori Ag [Presence] in Stool

1420

10877

1.33

21.82

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

407

2431

1.69

21.81

1.4

1.2

2.41

3.58

u/ml

1.76

182

898

(3036603) Volume of Urine

246

1266

1.96

21.53

1.6

1.7

1937.96

1980.58

0.32

240

1238

(3017569) Oxygen content in Arterial blood

190

890

2.15

21.49

2.8

2.2

15.11

16.01

3.34

190

890

(3004716) Salmonella sp identified in Stool by Organism specific culture

962

6954

1.41

21.32

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

232

1175

1.99

21.27

1.3

1.6

25.07

24.41

u/ml

0.06

220

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

124

485

2.57

21.18

2.8

2.7

136.25

127.91

au/ml

0.07

(3004775) Volume in Urine collected for unspecified duration

234

1193

1.97

21.06

2.1

2.4

742.64

670.65

1.26

152

827

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1103

8211

1.37

20.45

2.5

2.4

—

(3045716) Anion gap in Serum or Plasma by calculation

318

1812

1.77

20.21

3.8

3.2

10.87

10.83

mmol/l

0.08

313

1790

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

264

3.12

20.13

2.4

2.9

33.23

43.90

mg/l

0.35

(3045177) Copper [Moles/volume] in Urine

18.78

19.89

1.1

0.40

0.68

umol/l

—

(3008838) Granulocytes/Leukocytes in Peritoneal fluid

35.76

19.79

2.0

1.0

24.44

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

232

1208

1.93

19.67

1.4

1.3

14.35

14.79

u/l

0.06

211

1115

(3045414) Leukocytes [Presence] in Urine

1920

15520

1.27

19.51

2.3

2.1

0.02

estimate

0.11

357

3131

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

156

704

2.23

19.41

1.8

1.9

182.39

155.29

2.94

145

671

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

700

2.22

19.26

2.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

136

3.98

19.23

3.1

2.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.19

19.04

1.0

1.2

—

mmol/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

277

1544

1.81

18.99

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

216

1112

1.95

18.95

2.1

2.7

225.29

234.25

e6/l

0.21

179

951

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1314

10162

1.32

18.81

1.2

127.30

138.61

u/ml

0.48

441

3818

(3035880) pH of Pleural fluid

174

831

2.10

18.79

1.4

1.3

7.38

7.41

0.67

118

577

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

322

5339

0.60

18.70

1.1

0.64

ratio

0.06

723

(3014271) Vancomycin [Susceptibility]

149

671

2.23

18.65

3.4

2.8

—

(3017704) Immunofixation for Urine

174

834

2.10

18.61

1.4

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1715

13752

1.27

18.59

2.9

2.5

0.60

0.39

e6/l

1.97

1642

13163

(3016750) Collection duration of Urine

178

861

2.08

18.59

2.2

2.3

505.97

494.87

min

0.81

119

657

(3001893) Eosinophils/Leukocytes in Pleural fluid

113

451

2.52

18.57

1.5

1.4

3.23

2.70

0.21

390

(3003129) Base excess in Capillary blood by calculation

340

2026

1.69

18.45

2.5

2.3

0.00

0.51

mmol/l

1.33

333

1947

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

226

1193

1.91

18.42

2.0

14.33

15.55

0.85

218

1161

(1175426) CD3 cells/Lymphocytes in Blood

234

1252

1.88

18.31

2.0

74.60

72.65

1.16

224

1197

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

209

1078

1.95

18.26

2.0

2.6

539.85

515.56

e6/l

0.24

164

869

(3008116) Ketones [Moles/volume] in Urine by Test strip

368

2.67

18.23

1.7

1.4

0.24

0.32

mmol/l

0.32

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6929

63308

1.15

18.23

4.8

3.8

0.93

0.35

estimate

0.71

2011

13962

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

300

1733

1.74

18.23

1.7

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

631

4354

1.47

18.05

1.5

1.4

10.39

10.14

u/l

0.16

499

3476

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

281

1605

1.76

17.77

1.7

1.8

—

(40768446) Kidney Pathology biopsy report

149

685

2.19

17.76

1.6

1.7

—

(4195642) Thrombophilia screening test

365

2241

1.64

17.68

1.3

1.2

—

(3045424) Erythrocytes [Presence] in Urine

1052

7950

1.34

17.67

2.4

2.2

0.92

0.15

estimate

0.40

275

2435

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

367

2259

1.64

17.60

1.2

1.1

112.85

117.17

1.33

334

2053

(3044242) Glucose [Moles/volume] in Arterial blood

181

902

2.02

17.46

2.5

2.0

8.73

7.95

mmol/l

1.66

181

902

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

194

3.31

17.39

2.5

2.2

1.11

1.03

mmol/l

0.09

132

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

277

1586

1.76

17.38

3.6

3.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

154

726

2.13

17.24

2.2

2.1

97.46

125.01

ug/min

0.26

172

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

760

2.10

17.18

1.6

1.7

2.26

8.37

nmol/l

1.21

123

631

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

383

2399

1.61

17.13

1.3

0.16

0.24

nmol/l

1.81

160

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

221

1187

1.87

17.12

2.1

2.0

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

125

543

2.31

17.09

1.5

1.4

60.36

64.44

0.62

102

456

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

338

2054

1.66

17.06

1.3

0.24

0.20

nmol/l

0.32

258

1632

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

376

2350

1.61

16.97

1.3

0.64

2.56

nmol/l

1.23

366

2268

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

168

3.46

16.93

1.1

17.64

21.62

u/l

1.00

112

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

197

1029

1.92

16.63

1.2

1.3

1215.00

368.03

titre

0.84

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

207

1100

1.89

16.59

2.3

2.7

0.66

e9/l

0.01

196

1047

(3028433) Virus identified in Specimen by Culture

115

491

2.35

16.38

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

653

4622

1.43

16.34

1.4

—

(3003694) ABO and Rh group [Type] in Blood

4925

44201

1.16

16.01

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

199

1058

1.89

15.95

1.6

1.4

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

156

3.47

15.85

3.2

2.6

25.36

22.69

mg/l

0.52

147

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

118

520

2.28

15.64

1.9

229.90

176.87

3.22

113

496

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

226

1263

1.80

15.46

1.3

2.36

2.09

mmol/l

1.32

206

1184

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

159

3.40

15.40

1.1

1.2

0.13

0.33

u/ml

0.44

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

534

3684

1.46

15.34

1.3

4.05

3.79

mmol/l

4.25

497

3506

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

787

2.02

15.33

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

141

674

2.10

15.29

1.2

1.1

17.50

13.82

u/ml

0.10

(3002621) Streptococcal DNAse B [Units/volume] in Serum

136

3.61

15.28

1.0

1.1

351.27

304.72

u/ml

0.17

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1576

12802

1.25

15.21

1.5

—

(3045142) Bone marrow Pathology biopsy report

311

1907

1.64

15.21

1.3

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5274

58033

0.87

15.17

4.9

5.5

2.49

3.05

ug/l

0.93

4714

52852

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

169

866

1.96

15.14

1.2

1.1

1.08

1.06

ratio

0.56

148

705

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

277

2.75

15.06

1.2

1.1

31.92

29.73

iu/ml

—

(3000330) Specific gravity of Urine by Test strip

1019

7853

1.32

14.94

4.0

3.3

1.02

ratio

0.24

934

7086

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

188

1003

1.88

14.94

1.3

42.50

66.57

titre

0.88

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

160

809

1.99

14.90

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

587

4148

1.43

14.85

1.3

559.66

555.32

mg/l

0.04

561

3980

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

313

1938

1.63

14.74

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

286

2.70

14.73

3.8

2.6

1145.99

1616.42

u/l

0.23

260

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14711

151146

0.85

14.68

6.1

5.1

1.35

1.45

mmol/l

138.60

13810

141143

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

113

3.81

14.52

1.0

1.2

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

406

2.40

14.50

1.5

1.4

26.19

21.32

0.77

373

(3020911) Cortisol [Moles/time] in 24 hour Urine

116

525

2.22

14.47

1.4

296.22

198.24

nmol/24h

0.25

116

525

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

310

1925

1.62

14.44

3.5

3.6

4.55

12.88

nmol/l

1.34

292

1870

(4146454) Self-monitoring of blood glucose

286

1743

1.65

14.36

2.9

2.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

281

1707

1.66

14.29

1.5

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

223

1272

1.76

14.28

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

341

2176

1.58

14.18

2.6

2.3

5.00

9.85

titre

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

298

1842

1.63

14.15

2.1

1.9

4400.00

1980.49

titre

0.82

(3010503) CD19 cells [#/volume] in Blood

182

981

1.86

14.04

2.3

2.7

134.51

302.55

e6/l

1.28

177

947

(3044889) 12 lead EKG panel

11572

110447

1.14

14.01

4.9

4.1

0.23

3169.24

1.18

241

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

178

955

1.87

13.94

1.7

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

171

907

1.89

13.87

1.9

1.5

16.91

23.97

umol/l

3.40

160

844

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

162

3.22

13.61

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

103

456

2.27

13.58

1.1

80.94

87.53

1.30

213

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

239

1411

1.70

13.56

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

239

1411

1.70

13.56

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

239

1411

1.70

13.56

1.6

1.7

—

(4268621) Lupus anticoagulant assay

278

1709

1.64

13.52

2.5

2.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14574

141428

1.17

13.50

6.4

5.3

2.01

1.91

mu/l

7.65

13666

131242

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

190

1053

1.81

13.43

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

371

2445

1.53

13.39

2.0

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

181

990

1.84

13.36

1.6

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14822

151997

0.85

13.28

6.2

5.2

4.46

4.63

mmol/l

72.51

14026

142743

(3024666) Lithium [Moles/volume] in Serum or Plasma

161

851

1.90

13.23

13.3

13.8

0.60

0.64

mmol/l

1.23

155

774

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

224

2.82

13.13

1.5

1.4

13.03

10.84

0.27

122

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

191

1068

1.80

13.12

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

115

541

2.13

13.07

7.3

6.7

24.97

25.03

mmol/l

0.04

104

494

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15041

154034

0.85

13.07

7.0

5.9

2.57

2.71

mmol/l

70.20

14154

144112

(3011544) Albumin [Mass/volume] in Pleural fluid

151

3.25

13.07

1.2

14.65

18.08

g/l

1.97

135

(3021387) Prolactin [Units/volume] in Serum or Plasma

630

4617

1.38

12.94

1.8

286.09

289.19

mu/l

0.10

575

4217

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

103

466

2.22

12.91

1.1

1.2

96.62

106.82

1.42

432

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

511

3623

1.42

12.75

1.4

37.71

33.41

e6/l

0.07

363

2674

(3008536) Aspergillus sp Ab [Presence] in Serum

339

2.43

12.66

1.8

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

356

2355

1.52

12.66

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

587

4281

1.38

12.43

1.7

1.6

15192.78

14170.27

e6/l

0.22

402

3031

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

12369

128263

0.88

12.32

39.3

20.6

332.04

332.57

g/l

7.44

12307

127583

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

450

2.21

12.30

1.1

1.2

78.44

88.52

1.65

218

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

515

3681

1.41

12.29

1.5

1.4

1359.55

3114.99

e6/l

0.62

398

2909

(3023419) Bacteria identified in Sputum by Culture

336

2210

1.53

12.28

3.3

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

205

2.84

12.25

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

863

1.85

12.08

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

175

979

1.80

12.05

1.9

1.4

11.34

5.95

u/l

0.83

157

848

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

235

2.69

12.03

5.0

5.9

47.70

43.59

ug/min

0.27

185

(3049717) Cytology report of Urine Cyto stain

814

6275

1.31

11.94

2.5

2.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

242

2.65

11.91

10.7

5.63

5.40

mmol/l

0.14

242

(3004451) EKG impression Narrative

167

929

1.81

11.73

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

316

2.41

11.62

1.2

75.83

79.84

0.28

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.96

11.43

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

147

793

1.86

11.41

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

273

1744

1.57

11.40

1.2

1.1

99.18

97.31

0.52

259

1636

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

154

844

1.83

11.37

1.7

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

154

844

1.83

11.37

1.7

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

154

844

1.83

11.37

1.7

2.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

13132

126926

1.13

11.33

38.3

19.7

14.22

13.62

311.56

13045

125284

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

154

846

1.83

11.29

1.7

2.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1369

11312

1.23

11.25

2.5

2.4

19.36

21.87

au/ml

0.57

127

1223

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

217

1320

1.65

11.10

1.3

1.2

106.86

109.27

pmol/l

0.23

217

1320

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

317

2.37

11.09

1.2

68.85

71.38

0.17

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.70

11.08

1.0

1.1

44.64

46.94

u/l

0.09

(3006245) CD3-CD19+ cells/cells in Blood

120

614

1.96

10.94

1.9

2.2

9.69

9.72

0.01

108

570

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1270

10444

1.23

10.92

1.3

43.17

53.40

au/ml

0.92

690

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

193

1151

1.68

10.67

3.7

3.6

106.98

170.52

nmol/l

1.98

184

1140

(3012565) Volume of 24 hour Urine

146

804

1.82

10.65

2.2

2.1

2026.98

1977.48

0.21

132

716

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

525

2.03

10.61

3.4

3.2

4.62

4.94

kpa

1.69

106

525

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

526

2.02

10.56

3.4

3.2

10.77

10.31

kpa

0.65

106

526

(3023383) Lactate [Moles/volume] in Pleural fluid

466

2.09

10.54

1.5

1.3

3.71

3.46

mmol/l

0.23

426

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

125

658

1.91

10.51

1.5

2.1

39.17

40.23

g/l

1.07

125

658

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

117

606

1.94

10.33

1.8

2.1

29.67

30.03

0.10

109

575

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

300

2007

1.50

10.21

1.1

3.39

3.64

eliau/ml

0.09

937

(3020491) Glucose [Moles/volume] in Blood

182

1083

1.69

10.17

2.0

1.8

7.76

6.83

mmol/l

2.58

138

763

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

216

1345

1.61

10.11

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

263

2.44

10.10

1.7

1.6

104.18

113.21

ug/l

0.35

217

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

104

3.37

9.96

4.4

3.5

1.83

2.41

mg/l

1.25

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

212

2.60

9.92

1.2

1.5

6.68

231190.21

nmol/l

1.26

186

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

289

1931

1.50

9.91

2.5

2.0

20.25

25.95

mg/l

1.91

123

720

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

105

533

1.98

9.85

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

273

2.39

9.80

1.4

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

852

6785

1.27

9.76

1.4

28.51

30.43

iu/l

1.00

710

5785

(1761482) Bacteria [#/volume] in Urine by Culture

496

3670

1.36

9.70

4.8

4.0

—

(3000060) B lymphocytes [#/volume] in Blood

443

2.06

9.59

1.8

2.2

0.16

0.48

e9/l

0.94

207

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

116

617

1.89

9.50

1.8

2.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

130

717

1.82

9.49

3.1

3.5

1.23

1.32

0.22

130

717

(3043410) Blood group antigens tested for on Red Blood Cells

407

2.09

9.37

2.0

1.7

—

(21494814) CD8 cells/Lymphocytes in Specimen

120

653

1.84

9.17

2.1

2.0

31.73

31.66

0.01

120

653

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2184

19152

1.16

9.11

5.4

5.0

31.10

32.17

4.17

1685

12841

(3022621) pH of Urine by Test strip

1478

12555

1.19

9.10

3.1

2.6

5.99

6.05

1.59

1069

8389

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

459

2.01

9.10

1.3

8.71

357.97

ug/l

3.21

239

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

164

980

1.68

9.07

2.9

2.8

40.18

38.63

0.46

541

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

158

935

1.70

9.07

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.97

9.03

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

401

2.07

8.96

1.7

1.6

0.38

0.39

ug/l

0.15

286

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.45

8.89

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

396

2.08

8.87

1.2

1.3

—

(3007463) Buprenorphine [Presence] in Urine

4.47

8.81

9.2

7.6

—

(3047189) Immunofixation for 24 hour Urine

134

764

1.76

8.80

1.4

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

15863

155869

1.16

8.49

36.5

19.0

138.93

139.73

mmol/l

235.31

15696

152973

(3037692) Legionella sp identified in Specimen by Organism specific culture

108

585

1.85

8.41

1.3

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.56

8.37

1.1

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

290

2010

1.45

8.35

1.6

1.5

60.56

58.37

0.39

180

1264

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

111

612

1.82

8.19

1.9

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

111

612

1.82

8.19

1.9

2.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

375

2.06

8.18

1.4

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

7.51

8.13

2.0

2.1

23.64

31.10

0.75

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

113

628

1.80

8.12

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

140

829

1.69

8.07

1.1

1624.09

1518.36

miu/ml

0.61

140

829

(3000034) Microalbumin [Mass/volume] in Urine

208

1359

1.54

8.02

3.5

2.9

79.92

48.54

mg/l

0.74

157

976

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

460

1.94

8.02

2.3

3.5

2.18

1.84

ratio

0.76

421

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

133

780

1.71

7.95

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

210

1378

1.53

7.94

1.8

4.12

3.83

mg/l

0.41

199

1321

(3018291) Platelet Ab [Presence] in Serum

9.38

7.76

1.2

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

917

7562

1.22

7.73

3.3

3.8

84.63

59.86

u/ml

1.56

876

7315

(3002079) Sodium [Moles/time] in 24 hour Urine

132

781

1.70

7.66

1.2

155.72

166.05

mmol/24h

0.71

132

781

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

512

1.86

7.57

1.3

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15993

162194

0.87

7.56

39.4

21.0

81.90

78.61

umol/l

16.58

15869

160396

(3019420) Tryptase [Mass/volume] in Serum or Plasma

146

892

1.64

7.51

1.5

1.6

11.01

9.11

ug/l

0.28

139

812

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

193

1261

1.54

7.48

2.1

2.3

16.54

18.18

nmol/l

1.27

178

1191

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

303

2.12

7.36

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

236

1614

1.47

7.35

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

222

1500

1.49

7.34

1.6

1.5

27.89

30.15

0.42

139

908

(3026389) Candida sp identified in Specimen by Organism specific culture

323

2341

1.39

7.30

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.38

7.22

1.2

2924.82

3509.67

ng/l

0.16

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.48

7.16

1.5

1.7

363.60

210.63

nmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

287

2.13

7.14

1.7

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

487

1.85

7.11

1.3

136.08

126.70

nmol/l

0.13

360

(3008898) HLA-B27 [Presence]

647

5190

1.26

7.07

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

181

2.43

7.05

1.4

1.3

27.98

24.71

0.24

142

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

130

785

1.66

7.03

1.9

1.8

3.08

2.82

u/field

0.09

102

567

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

181

1184

1.53

7.01

1.3

0.93

1.99

u/ml

1.60

104

707

(3020393) Adenovirus Ag [Presence] in Stool

158

2.54

6.98

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15867

156210

1.14

6.95

36.8

19.1

3.96

3.98

mmol/l

12.90

15696

153065

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

245

2.21

6.93

2.0

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

507

3958

1.29

6.93

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

6.30

6.92

1.1

241.48

279.22

u/ml

0.35

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

543

1.79

6.88

1.2

0.32

0.30

g/l

0.77

446

(3038177) Helicobacter pylori Ab [Presence] in Serum

347

2576

1.35

6.78

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

292

2109

1.39

6.77

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

107

622

1.72

6.68

1.1

99.83

97.64

0.26

500

(40757494) Bilirubin.total [Moles/volume] in Blood

133

820

1.63

6.65

2.5

2.2

16.15

30.83

umol/l

1.06

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

455

1.85

6.64

11.5

7.7

5.83

6.00

kpa

1.12

408

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

436

1.86

6.54

1.7

2.0

51.20

34.21

u/l

0.37

399

(40768800) Prostate Pathology biopsy report

274

3761

0.72

6.49

1.2

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

354

1.95

6.44

1.5

1.4

20.80

23.89

0.42

299

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.13

6.42

1.1

1.2

1.00

1.07

u/field

0.30

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.29

6.39

1.0

0.04

0.53

u/ml

1.32

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

219

1521

1.45

6.36

1.7

392.66

344.06

mu/l

0.75

172

1207

(3032057) Clostridioides difficile [Presence] in Stool

308

2.02

6.34

2.0

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

265

3638

0.72

6.30

1.5

1.6

870.36

1002.72

mu/l

1.50

205

3019

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

181

1214

1.50

6.28

2.0

1.87

1.47

u/field

0.67

109

677

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

487

1.79

6.22

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

537

4290

1.26

6.13

2.0

1.9

3.45

7.10

iu/l

0.98

199

1747

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

139

885

1.58

6.13

1.2

—

(3034426) Prothrombin time (PT)

498

1.77

6.07

1.4

1.2

28.48

28.31

0.11

498

(3028717) Thiamine [Mass/volume] in Blood

220

2.18

6.06

1.2

60.21

64.13

ug/l

0.86

220

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

406

3138

1.30

6.05

1.4

185.30

161.28

pmol/l

0.40

396

3060

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

384

1.88

6.02

1.3

1.5

401.17

859.93

mu/l

0.89

366

(3034891) Synovial lining cells/cells in Synovial fluid

126

790

1.60

5.94

1.6

1.5

5.55

3.33

0.52

162

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

255

2.08

5.93

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

127

799

1.59

5.91

4.1

3.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1429

12561

1.15

5.76

2.1

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

120

750

1.60

5.75

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

434

1.80

5.72

1.1

1.0

6.55

9.85

u/ml

0.93

272

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

392

1.84

5.67

1.3

1.5

69.24

72.92

1.11

374

(3033099) Centromere Ab [Titer] in Serum

387

1.84

5.58

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

123

781

1.58

5.53

1.5

1.2

41.55

65.30

1.37

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

341

1.88

5.41

1.2

383.72

299.42

pmol/l

0.82

253

(3038071) Oxygen [Partial pressure] in Mixed venous blood

407

1.80

5.35

10.9

7.7

5.91

5.45

kpa

0.86

407

(3001019) Free T4 and TSH panel - Serum or Plasma

603

7298

0.82

5.34

1.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

474

1.73

5.32

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

474

1.73

5.32

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

474

1.73

5.32

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

474

1.73

5.32

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

336

1.88

5.32

5.0

7.0

55.49

70.36

2.14

260

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.28

5.29

1.3

0.80

1.11

u/field

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

267

1.99

5.28

1.3

2.0

53.34

49.24

pmol/l

0.14

227

(4024509) Urine culture

846

7193

1.18

5.26

2.1

1.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

261

2.00

5.24

1.4

1.2

1.59

1.24

mmol/l

0.11

177

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1541

13713

1.14

5.19

2.2

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.75

5.18

4.8

5.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

215

2.10

5.18

1.1

—

(44806071) Cardiolipin IgM antibody measurement

222

2.07

5.16

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

913

7827

1.18

5.15

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

3.00

5.09

6.2

4.5

9.98

16.09

0.65

(3018133) Calcium [Moles/volume] in Urine

320

1.88

5.08

1.7

1.9

2.85

2.71

mmol/l

0.18

289

(3009466) Valproate [Moles/volume] in Serum or Plasma

307

2345

1.31

5.06

5.2

5.5

349.68

362.63

umol/l

0.82

264

2052

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

147

994

1.48

5.00

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

424

1.75

4.98

1.6

1.5

—

(3002619) Bacteria identified in Specimen by Culture

439

1.73

4.97

1.4

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

219

2.06

4.95

1.3

—

87.33

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

123

2.44

4.94

1.2

1.1

1.13

1.88

iu/ml

2.18

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

277

2096

1.33

4.90

1.4

0.22

0.34

nmol/l

5.36

199

1538

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14763

145246

1.09

4.88

9.3

6.4

41.24

39.37

mmol/mol

84.04

14045

136296

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

503

4101

1.23

4.88

1.2

3.28

3.76

0.70

577

(3019768) Coxiella burnetii Ab [Presence] in Serum

100

2.60

4.87

1.0

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

127

839

1.52

4.85

10.0

6.2

69.95

4977.37

u/ml

0.58

145

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

143

2.31

4.82

1.3

1.2

98.41

106.43

ug/l

0.11

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

182

2.15

4.79

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.88

4.75

16.0

10.3

103.43

106.77

g/l

0.46

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

196

2.09

4.74

1.5

—

(3019150) Specific gravity of Urine by Refractometry

3962

37174

1.08

4.72

4.9

4.1

1.37

1.10

kg/l

0.35

2819

24595

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

308

1.85

4.67

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

308

1.85

4.67

1.2

1.3

79.36

72.71

mu/l

0.13

230

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

330

1.82

4.65

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

102

650

1.57

4.60

1.0

1.1

7.24

6.92

u/ml

0.05

106

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

179

2.13

4.57

3.9

3.1

1.33

1.20

mg/l

0.21

127

(3036071) Salmonella sp Ab [Titer] in Serum

473

1.67

4.57

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.80

4.54

8.4

9.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.55

4.53

1.2

0.23

0.71

iu/ml

2.27

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

180

2.11

4.51

1.1

0.01

0.35

u/ml

1.38

117

(3035320) C reactive protein [Mass/volume] in Body fluid

177

1267

1.40

4.49

3.4

2.6

23.56

29.16

mg/l

1.36

140

925

(3019832) Treponema pallidum Ab [Presence] in Serum

1255

11134

1.14

4.46

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

215

2.00

4.43

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

100

2.50

4.36

1.3

1.5

324.32

308.88

umol/24h

0.12

100

(3033923) Metanephrine [Moles/time] in 24 hour Urine

301

1.83

4.36

1.2

1.1

0.74

0.90

umol/24h

0.30

141

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

1.98

4.33

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

14963

147464

1.09

4.32

29.3

15.7

81.66

80.84

ml/min/173m2

4.35

14241

136690

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

178

1285

1.39

4.31

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

324

1.79

4.30

1.4

1.2

1.37

1.64

mmol/l

0.94

209

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

271

2087

1.30

4.28

1.3

1.4

26.27

30.84

u/l

1.36

207

1709

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

126

2.30

4.25

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1855

16890

1.11

4.23

1.7

1.6

—

7.16

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

172

2.10

4.20

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.50

4.20

1.1

45.87

29.54

u/ml

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

432

1.67

4.17

1.2

12.51

11.54

pmol/l

0.11

160

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

169

1219

1.39

4.13

1.3

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.80

4.11

1.2

1.3

2.11

1.86

mg/l

0.30

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

202

1.98

4.04

1.4

0.13

0.24

nmol/l

1.84

141

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

149

2075

0.72

4.03

1.4

1.5

52.09

61.34

ug/l

1.91

110

1718

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15932

160953

0.91

3.99

25.3

12.1

41.70

26.47

u/l

175.13

15719

156538

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

339

4214

0.80

3.98

1.4

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7007

67427

1.06

3.98

2.2

1.9

1.56

1.37

mmol/l

34.10

5943

56653

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.53

3.95

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

170

2.06

3.94

2.4

2.7

0.34

0.51

u/field

0.65

170

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

212

1.94

3.89

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.07

3.89

1.5

1.8

154.43

222.85

nmol/l

—

(3007919) Fasciola sp Ab [Titer] in Serum

4.78

3.86

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

316

1.74

3.76

2.9

2.2

8.17

7.67

mmol/l

0.33

199

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

187

1.98

3.76

1.2

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

229

1.88

3.75

1.6

1.2

171.77

185.18

u/l

0.03

168

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

170

1252

1.36

3.71

1.2

1.1

45.41

42.07

mg/l

0.28

137

1072

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

165

1210

1.37

3.70

1.1

248.91

274.35

mg/l

1.31

139

1088

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

168

2.03

3.68

1.6

1.3

72.64

70.96

0.10

142

(3050129) First trimester maternal screen panel - Serum or Plasma

180

2389

0.75

3.61

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.74

3.58

1.1

236.82

258.83

nmol/l

0.31

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

130

2.16

3.56

1.2

1.1

16.27

13.17

iu/ml

0.18

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

140

1921

0.73

3.51

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

249

1.81

3.51

1.4

1.2

91.81

449.82

ng/l

0.56

165

(3028468) Fragments [Presence] in Blood by Light microscopy

10.00

3.49

1.0

—

(3005570) Glucose [Moles/volume] in Urine

200

1526

1.31

3.47

2.3

1.9

—

1.35

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

140

2.07

3.36

2.4

2.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

404

1.61

3.36

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

305

1.71

3.35

1.5

2.0

16.94

16.39

umol/l

0.14

305

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

515

1.54

3.34

1.2

1.5

14.06

15.61

pmol/l

1.89

424

(3002814) Trichinella spiralis Ab [Titer] in Serum

5.72

3.33

1.3

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

210

1.86

3.33

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

175

1.94

3.32

1.1

1.0

—

(3036180) Methadone [Presence] in Urine

4.35

3.30

2.3

2.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

144

1946

0.74

3.30

1.4

1.5

0.93

0.95

ratio

0.28

1166

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

144

1946

0.74

3.30

1.4

1.5

1.19

1.21

ratio

0.11

1172

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

144

1942

0.74

3.26

1.4

1.5

1.07

1.16

ratio

0.61

1162

(4015189) Microbial culture of sputum

408

1.60

3.24

2.6

2.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.38

3.21

1.3

1.2

0.04

0.07

g/l

3.52

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

394

1.60

3.19

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

272

1.73

3.19

1.3

1.2

—

(3001556) Androgen free Index in Serum or Plasma

2.27

3.18

1.4

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

513

1.52

3.18

1.1

1.2

55.89

22.95

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

171

1.93

3.17

1.2

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

2.96

3.13

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.62

3.12

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

276

2226

1.24

3.11

1.1

2.07

2.74

0.72

370

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

516

1.51

3.11

2.1

2.6

1.09

1.01

ug/l

0.14

490

(3043238) Trisomy 21 risk [Likelihood] in Fetus

121

1661

0.73

3.10

1.4

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.67

3.08

1.4

1.5

3.00

1.91

mmol/24h

0.58

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

406

1.58

3.07

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

125

2.08

3.07

1.1

1.3

18.87

16.23

nmol/l

—

(3005033) Fetal Nuchal fold Thickness US

115

1588

0.72

3.06

1.4

1.5

1.22

1.26

0.58

1132

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

692

1.43

3.01

1.3

3.81

4.24

umol/l

0.60

610

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

150

1125

1.34

2.99

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

370

1.60

2.98

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.63

2.96

1.0

1.1

—

(3014891) Appearance of Pleural fluid

190

1.84

2.95

2.1

1.5

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

3.24

2.92

7.2

8.9

46.67

52.29

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

121

2.07

2.91

1.5

17.66

18.01

pmol/l

0.03

102

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14274

144514

0.94

2.88

5.2

4.4

1.49

1.31

mmol/l

101.98

13291

133726

(3047352) Trisomy 18 risk [Likelihood] in Fetus

119

1613

0.74

2.84

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

305

1.64

2.84

1.6

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.64

2.79

1.1

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.57

2.78

1.0

1.3

1.90

2.22

g/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

507

1.48

2.74

1.3

38.76

40.24

g/l

0.34

258

(3012494) Peanut IgE Ab [Units/volume] in Serum

355

1.58

2.74

1.1

0.66

4.29

u/ml

0.87

195

(3036048) Francisella tularensis Ab [Titer] in Serum

387

1.55

2.72

1.1

1.2

—

394.78

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1312

0.71

2.72

1.4

1.5

52.52

60.96

ug/l

1.33

1312

(4027681) Cerebrospinal fluid IgG ratio and IgG index

124

919

1.35

2.71

1.4

1.2

0.55

0.67

ratio

0.91

545

(3034614) HLA Ag [Interpretation]

3.45

2.68

1.1

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

0.35

3.28

mg/l

4.47

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

4.20

1.97

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

1.22

2.03

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

4.43

3.53

mg/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

105

2.10

2.67

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

0.32

2.25

mg/l

3.13

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

1.53

2.81

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

0.40

1.16

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

3.72

0.74

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

105

2.10

2.67

1.5

1.6

1.00

2.02

mg/l

0.86

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

4.21

2.67

1.0

1.1

0.06

0.64

u/ml

—

(3006270) Folate [Moles/volume] in Blood

157

1207

1.30

2.67

1.1

1.2

352.65

359.98

nmol/l

0.17

125

1025

(3045683) HLA typing for celiac disease panel - Blood or Tissue

118

874

1.35

2.60

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

297

1.62

2.60

1.3

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.30

2.57

1.6

1.3

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.86

2.54

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

600

1.42

2.51

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

1.82

2.48

1.1

—

(3006462) Nitrate [Presence] in Urine

686

1.39

2.47

3.1

3.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

544

1.44

2.47

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

109

2.02

2.45

1.5

1.6

2.81

1.95

mg/l

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.67

2.44

8.1

8.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

130

989

1.32

2.42

1.1

7.23

7.72

nmol/l

0.04

183

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

367

1.53

2.41

1.3

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

5.00

2.40

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

110

2.00

2.40

3.5

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

322

0.47

2.39

2.5

3.0

42.00

43.88

0.17

322

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

321

0.47

2.37

5.1

6.1

11.73

8.76

1.01

321

(3017509) Phencyclidine [Presence] in Urine

146

1.85

2.36

2.9

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

317

2676

1.19

2.35

1.6

—

(3013762) Body weight Measured

2.61

2.35

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

2.02

2.35

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

418

1.48

2.35

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

475

0.57

2.32

1.4

1.5

—

(44806420) Estimation of glomerular filtration rate

210

1709

1.23

2.29

2.8

2.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

200

1.70

2.27

2.9

3.3

38.72

39.68

umol/l

0.11

171

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

190

1533

1.24

2.25

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

196

1588

1.24

2.23

1.4

177436.23

116566.63

e6/l

0.52

125

1056

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

114

864

1.32

2.21

1.1

1.10

u/l

0.01

363

(4211845) Urine protein measurement

101

755

1.34

2.16

3.1

3.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.62

2.14

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.45

2.10

1.4

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

316

1.52

2.07

9.0

7.1

10.50

0.00

316

(3014178) Parietal cell Ab [Units/volume] in Serum

5.00

2.07

1.4

1.0

60.00

57.80

u/ml

—

(3025130) Human papilloma virus identified in Specimen

240

2003

1.20

2.07

1.9

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.70

2.06

2.3

2.0

278.74

259.68

ug/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

271

2293

1.18

2.01

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

118

1.87

2.01

1.3

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

272

1.55

1.96

1.0

1.1

0.44

2.09

u/ml

1.00

232

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

337

1.49

1.95

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

3.75

1.93

2.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

234

1.58

1.92

1.9

2.0

—

(36303858) Crystals [Presence] in Urine

3.18

1.88

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.31

1.87

1.2

1.00

1.50

u/field

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

189

1.64

1.86

1.1

—

(3047185) IgG [Mass/volume] in Urine

2.65

1.86

1.0

1.1

—

45.20

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.98

1.84

1.1

—

(3024263) Appearance of Synovial fluid

108

839

1.29

1.82

1.9

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

1305

1.23

1.79

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

105

1341

0.78

1.77

1.4

1.3

139.32

177.78

pmol/l

2.53

105

1341

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

694

1.31

1.76

2.6

2.3

51.46

52.94

umol/l

0.15

610

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.90

1.74

3.8

3.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

2.92

1.72

1.0

1.3

—

(40765096) Chromosome analysis panel by Banding

507

1.36

1.72

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

103

1.85

1.71

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.29

1.70

1.1

0.05

0.04

u/ml

0.36

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

143

1754

0.81

1.70

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

961

0.75

1.70

1.3

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.06

1.69

3.9

4.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

259

1.51

1.67

1.2

1.3

39.06

42.23

mg/l

0.13

221

(3019174) dRVVT (LA screen)

119

1.77

1.65

1.1

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.44

1.64

1.1

32.11

32.15

mg/24h

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.69

1.58

1.1

1.5

492.14

407.27

mg/24h

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

305

1.44

1.55

1.6

3.3

94.79

127.53

ng/l

0.70

143

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

153

1.63

1.52

1.5

1.7

—

(4212803) Bone marrow aspirate examination

138

1.67

1.51

1.0

1.1

—

(40761511) CBC panel - Blood by Automated count

15508

156062

0.95

1.45

26.8

14.3

—

126.70

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

463

1.34

1.44

1.1

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.92

1.43

1.6

0.40

0.06

u/l

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

2.73

1.43

1.0

1.2

77.33

81.69

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

303

0.59

1.42

1.6

1.8

2.17

2.11

ug/l

0.04

166

(3000285) Sodium [Moles/volume] in Blood

311

1.42

1.3

1.2

138.16

138.54

mmol/l

0.24

255

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

129

1559

0.83

1.38

1.8

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.80

1.36

1.1

1.3

—

10925.00

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

135

1.63

1.35

1.8

2.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

292

2579

1.13

1.34

1.1

21.38

14.43

au/ml

0.45

662

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

709

0.75

1.33

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

144

1.60

1.31

1.5

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.35

1.29

3.1

5.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.78

1.28

1.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

116

0.43

1.24

1.8

1.2

39.80

67.20

ug/l

—

116

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

117

0.43

1.24

1.2

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1190

0.81

1.24

1.0

36.34

40.21

ng/l

0.47

853

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.91

1.22

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.96

1.22

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

192

1665

1.15

1.18

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

358

1.34

1.17

1.3

1.4

1.17

mmol/l

0.27

358

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

157

1.53

1.16

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

685

1.24

1.16

1.3

—

(3041184) Isoniazid [Presence] in Urine

2.50

1.15

3.4

2.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

150

1.53

1.14

1.1

1.4

10.19

16.91

pmol/l

0.82

127

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

224

1.43

1.13

1.1

0.02

4.65

u/ml

1.06

152

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.68

1.13

17.8

10.3

54.73

272.15

e6/l

1.21

(46235168) Fasting glucose [Moles/volume] in Blood

196

0.56

1.12

1.7

2.4

8.70

7.39

mmol/l

—

(3044009) aPTT.lupus sensitive (LA screen)

119

1.60

1.11

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

242

1.41

1.11

2.2

1.8

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

424

0.71

1.11

1.1

1.2

55.66

65.55

u/ml

0.45

413

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

255

2269

1.13

1.09

1.9

2.0

28.34

24.89

ug/l

0.23

247

2222

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

104

1.64

1.09

1.2

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.19

1.08

1.3

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1779

18524

0.96

1.06

10.9

6.9

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.12

1.05

1.1

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

129

1.55

1.05

1.0

0.13

0.36

u/ml

0.42

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1186

0.83

1.04

1.0

811.63

744.96

ng/l

0.61

843

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.27

1.03

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.27

1.03

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.27

1.03

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.27

1.03

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.27

1.03

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.27

1.03

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.83

1.02

1.1

0.00

0.51

u/ml

1.03

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1184

0.84

1.02

1.0

313.06

316.77

ng/l

0.04

868

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

114

1.58

1.02

2.7

5.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

572

1.24

1.01

2.7

3.1

25.09

28.49

umol/l

1.71

443

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

775

7285

1.07

1.01

2.4

2.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

107

1.59

0.99

1.2

10.20

18.81

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

130

1113

1.17

0.99

1.1

7.44

8.73

iu/ml

0.37

293

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

123

1.55

0.99

1.0

0.13

2.35

u/ml

0.71

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.94

0.97

1.3

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

327

1.32

0.96

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

116

1.55

0.96

3.1

2.1

0.62

0.64

ug/l

0.10

116

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

704

1.21

0.95

1.3

1.2

14.59

10.10

mm/h

2.03

704

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

141

1.49

0.94

1.1

1.78

umol/24h

0.01

141

(3010726) Horse dander IgE Ab [Units/volume] in Serum

276

2497

1.11

0.92

1.1

1.52

1.40

u/ml

0.07

148

1245

(3006567) Chloride [Moles/time] in 24 hour Urine

2.14

0.91

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.00

0.87

2.0

3.0

—

(3012898) Urea [Moles/volume] in Urine

187

1.39

0.84

1.1

1.3

186.14

172.53

mmol/l

0.21

163

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.59

0.84

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

615

1.20

0.83

2.2

2.6

154.98

146.77

nmol/l

0.29

543

(3041806) Other cells [#/volume] in Blood by Manual count

296

0.71

0.82

1.7

1.5

0.67

0.51

e9/l

2.22

296

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

638

6018

1.06

0.80

2.3

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

198

1.36

0.79

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

224

1.34

0.79

1.4

1.3

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.79

0.0

1.9

—

14.41

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

120

1045

1.15

0.78

1.3

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

106

1.51

0.78

1.1

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

131

1.45

0.78

1.0

0.03

3.29

u/ml

0.53

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.62

0.78

1.0

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.70

0.75

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

439

4694

0.93

0.74

1.6

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

201

1.34

0.74

2.0

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

201

1.34

0.74

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

132

0.61

0.73

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.00

0.72

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

134

1.42

0.71

1.1

0.04

u/ml

0.09

134

(40762887) Creatinine [Moles/volume] in Blood

126

1.43

0.70

1.4

1.5

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.53

0.68

1.1

1.0

0.96

0.52

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

293

2708

1.08

0.68

1.1

4.05

4.56

u/ml

0.32

150

1394

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.63

0.66

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

136

1.40

0.66

3.1

2.8

49.42

50.47

pmol/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

128

1.41

0.65

1.0

0.06

0.55

u/ml

—

(4034850) Laboratory test

465

4933

0.94

0.65

16.1

9.9

—

(3050794) Legionella sp Ab [Presence] in Serum

163

1.35

0.64

1.3

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

156

1406

1.11

0.63

4.9

5.6

152.83

95.00

u/ml

0.30

460

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

483

4562

1.06

0.63

2.0

1.9

191.51

204.42

pmol/l

2.09

459

4341

(3032352) Blasts [#/volume] in Cerebral spinal fluid

181

1.33

0.62

2.0

2.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.67

0.61

1.8

4.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

296

2755

1.08

0.60

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

100

883

1.13

0.59

1.0

1.1

1.42

1.79

u/ml

0.18

272

(3014133) Dog dander IgE Ab [Units/volume] in Serum

237

2190

1.08

0.59

1.1

2.61

3.47

u/ml

0.63

122

1047

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.58

0.0

1.0

—

161.26

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

161

1465

1.10

0.57

3.7

4.3

78.30

65.64

u/ml

0.26

156

1447

(3051101) Glucose [Moles/volume] in Cord blood

265

1.25

0.56

7.2

5.7

8.82

8.54

mmol/l

0.23

265

(3002523) Influenza virus A Ag [Presence] in Specimen

295

2756

1.07

0.56

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.57

0.56

1.0

1.1

—

(4133840) Spirometry

451

0.82

0.55

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.54

0.55

1.0

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

261

2430

1.08

0.55

3.5

3.8

26.88

37.54

u/ml

1.74

250

2355

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

615

5877

1.05

0.54

1.9

41.49

41.28

nmol/l

0.07

595

5730

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

333

3128

1.07

0.54

1.1

2.03

1.97

u/ml

0.04

179

1658

(3015076) Soybean IgE Ab [Units/volume] in Serum

802

0.87

0.52

1.0

0.45

1.65

u/ml

0.72

184

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

203

0.74

0.51

1.1

1.0

8.38

8.01

u/ml

0.03

203

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.41

0.50

1.0

1.1

—

(40768793) Breast Pathology biopsy report

324

3438

0.94

0.50

1.4

1.3

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

101

1.39

0.49

2.3

1.6

1.06

0.77

0.16

(3029396) Erythrocyte agglutination [Presence] in Blood

243

1.23

0.49

2.5

2.7

—

(3001729) Color of Synovial fluid

119

1.34

0.48

2.1

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

143

0.70

0.47

1.1

1.2

6.42

6.13

mmol/l

—

143

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

120

1.33

0.46

1.3

1.1

6.69

11.06

u/l

0.77

120

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

524

1.15

0.45

2.1

1.9

497.96

1179.48

pmol/l

0.29

(40763590) HLA-DQ beta [Type]

1.45

0.44

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14800

147512

1.02

0.44

6.5

5.2

6.38

5.96

mmol/l

169.15

13854

136259

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

266

1.20

0.43

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

266

1.20

0.43

1.0

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.61

0.43

1.2

1.0

0.06

0.10

u/ml

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

230

1.22

0.42

1.0

1.1

84.50

82.43

ug/l

0.06

177

(21494567) Legionella sp IgM Ab [Presence] in Serum

131

1.30

0.42

1.3

1.1

—

0.39

—

(46236302) HLA-C [Type] by High resolution typing

1.43

0.41

1.0

—

(40760409) HLA-A [Type] by High resolution

1.43

0.41

1.0

—

(40760410) HLA-B [Type] by High resolution

1.43

0.41

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

158

1.27

0.41

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.35

0.41

1.1

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

458

4777

0.96

0.40

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

700

1.11

0.40

1.1

47.00

453.68

ng/l

2.08

183

(3023430) Cat dander IgE Ab [Units/volume] in Serum

220

2070

1.06

0.39

1.1

3.31

3.91

u/ml

0.22

100

885

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

205

1.22

0.39

2.4

2.3

—

(4038314) Semen analysis, post vasectomy

1.38

0.38

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.39

0.38

1.0

1.1

3.00

3.08

—

(40762814) Titanium [Mass/volume] in Blood

258

0.81

0.38

2.6

2.5

2.92

3.79

ug/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.33

0.37

1.0

0.02

0.23

u/ml

0.92

(3013862) HLA-DP [Type]

1.39

0.36

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.39

0.36

1.1

1.0

0.14

0.73

u/ml

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.39

0.36

1.3

1.2

0.12

1.72

u/ml

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.66

0.35

1.0

—

0.16

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.63

0.35

1.2

1.5

198.04

564.32

nmol/l

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.36

0.34

1.0

1.1

23.49

64.80

umol/24h

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

414

1.14

0.34

1.4

1.3

30.50

39.86

0.83

284

(3008401) Mugwort IgE Ab [Units/volume] in Serum

275

2620

1.05

0.34

1.1

0.73

1.11

u/ml

1.00

128

1135

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

266

1.17

0.32

1.0

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

873

0.92

0.31

1.0

0.66

1.58

u/ml

1.16

206

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

563

5458

1.03

0.31

1.9

1.8

4.65

4.48

mg/l

0.15

492

4061

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

138

1.23

0.30

1.2

1.1

88.47

91.59

titre

0.08

138

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

102

1.27

0.30

1.0

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

206

1.17

0.26

1.2

1.3

56.20

56.01

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

336

3249

1.03

0.24

4.6

3.5

27.83

27.89

mg/l

0.01

249

2257

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.17

0.24

1.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

929

0.94

0.23

2.3

2.2

2.53

2.32

ug/l

0.09

767

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.77

0.22

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

7.7

—

(3022475) Manganese [Moles/volume] in Blood

102

0.78

0.21

1.0

1.3

0.17

0.16

umol/l

—

102

(3009992) Blasts/cells in Bone marrow

0.00

0.21

0.0

1.8

—

11.31

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

505

5168

0.98

0.20

1.7

1.8

—

32.21

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.25

0.20

2.2

2.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

165

1.15

0.19

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

137

1.17

0.18

2.1

1.7

36.12

47.95

umol/l

1.40

137

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

153

0.85

0.18

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

102

1069

0.95

0.16

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

319

0.91

0.16

1.0

1.1

22.26

35.58

iu/ml

1.42

319

(40758292) HTLV I+II Ab panel - Serum

321

1.09

0.16

1.2

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

189

1.11

0.13

1.5

1.2

6.69

6.52

mmol/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

617

1.05

0.13

1.7

2.65

2.42

u/ml

0.04

169

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

193

1878

1.03

0.13

1.1

1.0

0.24

0.40

u/ml

0.55

607

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2069

20840

0.99

0.13

1.5

—

(3020650) Glucose [Presence] in Urine

541

1.05

0.12

2.1

1.6

0.02

0.04

estimate

0.50

541

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1574

15619

1.01

0.11

2.6

2.3

12.78

13.37

nmol/l

2.03

1394

14230

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

120

1164

1.03

0.10

1.4

1.5

3.18

3.85

ug/l

0.57

968

(3016031) Almond IgE Ab [Units/volume] in Serum

1.15

0.09

1.1

1.0

0.18

0.51

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

941

1.03

0.09

6.9

7.3

50.82

99.03

ug/l

0.55

617

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

200

1964

1.02

0.08

1.3

8.19

7.40

mmol/l

2.33

171

1716

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

480

0.96

0.08

2.1

1.8

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.07

0.07

1.0

—

(44813793) Dust mix specific IgE antibody measurement

113

1104

1.02

0.07

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.83

0.07

1.3

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

325

1.05

0.06

1.2

0.77

85.11

mg/l

1.90

237

(40765089) Chromosome analysis panel - Blood by G-banded

344

0.96

0.05

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

110

1082

1.02

0.04

1.1

19.30

19.51

u/ml

0.03

444

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

227

0.97

0.01

7.0

8.8

0.30

0.35

umol/l

0.31

205

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

112

0.98

0.00

3.7

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.94

-0.00

1.2

1.1

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

4.20

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

15.33

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

18.00

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.95

-0.00

1.1

8.73

8.24

mmol/l

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_LIVER and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_LIVER	3.269 [2.98, 3.59]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.031

During the follow-up period (1.1.1998 — 31.12.2019), 10429 out of 36669 females with K11_LIVER died.

Males

Parameter	HR [95% CI]	p-value
K11_LIVER	5.394 [4.85, 6.0]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 18403 out of 43303 males with K11_LIVER died.

Mortality risk

Mortality risk for people of age

years, who have K11_LIVER.

N-year risk	Females	Males
1	0.298%	0.756%
5	1.544%	5.108%
10	3.989%	12.745%
15	7.147%	23.705%
20	12.7%	37.641%

Relationships between endpoints

↥

Index endpoint: K11_LIVER – Diseases of liver

GWS hits: 13

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diseases of liver

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints